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ABSTRACT

MICROTECHNOLOGIES FOR MIMICKING TUMOR-IMPOSED TRANSPORT
LIMITATIONS AND DEVELOPING TARGETED CANCER THERAPIES

FEBRUARY 2012
BHUSHAN J. TOLEY
B.CHEM.ENGG., THE INSTITUTE OF CHEMICAL TECHNOLOGY, MUMBAI
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Neil S. Forbes

Intravenously delivered cancer drugs face transport limitations at the tumor site and
cannot reach all parts of tumors at therapeutically effective concentrations. Transport
limitations also prevent oxygen from distributing evenly in tumors resulting in hypoxia,
which plays a critical role in cancer progression. In this dissertation, I present the
development of micro-devices that mimic transport limitations of drugs and nutrients on
three dimensional tumor tissues, enable visualization and quantification of the ensuing
gradients, and enable simple analysis and mathematical modeling of obtained data. To
measure the independent effects of oxygen gradients on tumor tissues, an oxygen
delivery device that used microelectrodes to generate oxygen directly underneath threedimensional tumor cylindroids was developed. Supplying oxygen for 60 hours eliminated
the necrotic region typically found in the center of cylindroids. Dead cells were observed
moving away from the location of oxygen delivery. These measurements show that
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oxygen gradients are an important determinant of cell viability and rearrangement.
Another micro-device was developed to mimic the delivery and systemic clearance of
therapeutic agents. This microfluidic device consisted of cuboidal tumor tissue subjected
to continuous medium perfusion along one face. The device was used to measure the
spatiotemporal dynamics of the accumulation of therapeutic bacteria in tumors.
Suspensions of Salmonella typhimurium and Escherichia coli strains were delivered to
tumor tissues for 1 hour. Bacterial motility strongly correlated (R2 = 99.3%) with the
extent of tissue accumulation. Based on spatio-temporal profiles and a mathematical
model of motility and growth, bacterial dispersion was found to be necessary for deep
penetration into tissue. These results show that motility is critical for effective
distribution of bacteria in tumors. The microfluidic device was further used to mimic the
delivery and clearance of equal concentrations of doxorubicin and liposome-encapsulated
doxorubicin

(Doxil).

A

pharmacokinetic/pharmacodynamic

model

incorporating

mechanisms of tissue-level diffusion and binding was developed and experimental data
was fit to this model. Doxorubicin was found to have the optimal diffusivity and binding
for maximizing therapeutic effect. Doxil was severely limited by low intratumor drug
release. These results show that in-vitro models mimicking tissue-level transport
limitations more accurately predict the therapeutic response of drugs.
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CHAPTER 1
INTRODUCTION AND BACKGROUND

The organization of cells in the human body is remarkable. Each cell within the body is
located within a few cell diameters of blood vessels, ensuring an efficient nutrient supply
and waste drainage mechanism. This organization is maintained by precisely controlled
cell growth and death mechanisms within bodily tissue. Tumors, owing to genetic
malfunction, have lost this precision in controlling growth and death of cells. Cells in
tumors often grow faster than cells that would form blood vessels within them, creating
regions that have cells located at large distances from vessels (Minchinton and Tannock
2006). Nutrients supplied through the vessels are unable to reach these distant locations.
Further, the density of blood vessels in tumors is low, their architecture is disorganized,
and the blood flow through them is irregular (Gulledge and Dewhirst 1996). The
extracellular matrix in tumors is often extensive and slows down transport of molecules
through it (Jain 1994). Because of these conditions, newer microenvironments begin to
emerge within tumors. Populations of cells in tumors become hypoxic, hypoglycemic,
acidic, as well as quiescent and necrotic; each of these conditions affects tumors in their
own physiological ways. An important outcome of these conditions is that intravenously
delivered drugs face transport limitations at the tumor site, which prevents drugs from
reaching all parts of tumors in therapeutically effective concentrations. This inability to
treat all regions within the tumor is one of the major limitations of current cancer
therapies. To make progress in cancer therapy, new therapies that can overcome these

1	
  

transport limitations must be developed, while continually making progress in developing
understanding of innate tumor progression mechanisms.

In vitro models of tumors have proven to be indispensable tools in gaining insights into
cancer cell behavior. The structure, physiology, and behavior of real tumors are not
accurately reproduced by monolayer cultures. This makes it essential to develop suitable
models of three-dimensional (3D) tumor tissue. Multicellular tumor spheroids recreate
the microenvironments and metabolite gradients that exist in real tumors (Kasinskas and
Forbes 2006; Kim and Forbes 2008). When grown in cell culture medium, the peripheral
regions of spheroids remain viable due to proximity of nutrients. The central regions of
spheroids become hypoxic and hypoglycemic due to rapid consumption and diffusion
limitations on oxygen and glucose (Casciari et al. 1992). Such nutrient gradients exist in
real tumors because of limitations of nutrient transport from blood vessels into the
interstitium. Compressing spheroids in between two parallel surfaces forms cylindroids
that provide better optical accessibility (Kasinskas and Forbes 2006). Spheroids and
cylindroids successfully mimic localized regions of tumors.

The clearance of cancer therapies by metabolism, excretion, and distribution in tissues is
an important phenomenon that is integrally tied to a cancer drug’s therapeutic efficacy.
Chemotherapies are often limited by rapid systemic clearance. Spheroid and cylindroid
models, and most other existing in vitro tumor tissue models, do not mimic systemic
clearance of drugs. Consequently, techniques that can test the long-term effect of cancer
therapies on tumor tissue do not exist. The recent advances in microfluidic cell culture
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provide a way of addressing this limitation. Microfluidics provides a way to culture cells
under continuous medium perfusion and is an apt way of mimicking blood flow, drug
delivery, and systemic clearance. There have been several efforts to house cell cultures in
microfluidic devices (Hung et al. 2005; Korin et al. 2007; Prokop et al. 2004; Toh et al.
2007; Zietarska et al. 2007).

Targeted cancer therapies are designed to specifically treat tumors and have minimal
toxicity to other bodily tissues. Specificity is also achieved by targeting particular
microenvironments within tumors. Nanoparticles have great potential as controllable drug
delivery vehicles because of their size and modular functionality. In cancer cell cultures,
particle surface properties have been shown to regulate cellular uptake, intracellular
release and distribution in subcellular compartments (Chithrani and Chan 2007; Rosi et
al. 2006; Thomas and Klibanov 2003). Therapeutic bacteria have other mechanisms of
overcoming limitations of chemotherapeutics (Forbes 2010). Chemotherapeutic drugs are
limited by poor penetration, lack of specificity and excessive cytotoxicity. Therapeutic
bacteria can a) actively diffuse deep into tumor tissue, b) be genetically modified to
enhance specificity towards tumors, and c) to express cytotoxins (St Jean et al. 2008).
Several genera of bacteria have been shown to accumulate preferentially in tumors
compared to other organs and control tumor growth and enhance animal survival. The
motility of bacteria provides a way to overcome transport limitations because motile
bacteria can swim deep into tumors. Salmonella typhimurium, strain VNP20009, was
engineered to eliminate its native toxicity to humans and has been tested in three human
clinical trials for their ability to colonize in tumors (Clairmont et al. 2000a; Luo et al.
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2001; Toso et al. 2002).

In this dissertation, I describe the development of new devices and techniques based on
the spheroid and cylindroid model that mimic transport limitations faced by drugs and
nutrients. Microfabrication and microfluidic techniques were used to culture tumor
tissues in new ways to create different geometries and nutrient gradients. Specifically, I
will describe my work in the following areas:
i.

Measuring the effects of modified oxygen gradients on tumor tissue

ii.

Measuring the effects of surface charge of gold nanoparticles on doxorubicin
delivery in tumor tissue

iii.

Developing a microfluidic device for long-term continuously perfused culture of
tumor tissue

iv.

Measuring the effects of motility on the distribution of therapeutic bacteria in
tumor tissue

v.

Measuring the transport and binding of chemotherapeutic agents in tumor tissue
and developing a mathematical model to predict a drug’s efficacy by
incorporating pharmacokinetics, pharmacodynamics, transport, and binding.

1.1 The effects of modified oxygen gradients on tumors
Oxygen availability plays a critical role in the progression of cancer (Osinsky et al. 2009;
Tatum et al. 2006), and steep oxygen gradients are present in most tumors (Helmlinger et
al. 1997). Despite their importance, the independent effects of oxygen gradients on tumor
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tissues are unknown. In tumors limited oxygen, or hypoxia, has been correlated with poor
prognosis for several cancers, including cervical, head and neck, prostate, pancreatic and
brain (Brizel et al. 1997; Osinsky et al. 2009; Tatum et al. 2006; Vaupel and Mayer
2007). Hypoxia has also been shown to correlate with resistance to therapy (Huang et al.
2010; Vaupel et al. 2005) and distant metastases (Ackerstaff et al. 2007; Brizel et al.
1996; Tatum et al. 2006). Hypoxia may increase therapeutic resistance by slowing cell
growth (Kim and Forbes 2008), but it is not clear if oxygen alone can control cell
viability when other nutrient gradients are present (Kim and Forbes 2007). Similarly,
hypoxia may promote metastasis by increasing cellular invasiveness (Finger and Giaccia
2010), but it has never been shown that cells rearrange in tumor tissues in response to
oxygen gradients.

Many microenvironment factors reduce cell growth and limit the efficacy of cancer
therapeutics (Minchinton and Tannock 2006; Tredan et al. 2007). Hypoxia is thought to
be the dominant factor (Tannock 2001), but it is unknown how large a role oxygen plays,
and if it can control cell viability alone. Other factors that have been shown to slow
proliferation and cause cell death in tumors are hypoglycemia (Casciari et al. 1988),
acidosis (Helmlinger et al. 2002), and reduced supply of glutamine (Kim and Forbes
2008). Reports about the effects of oxygen on tumor tissue have been contradictory. In
spontaneous canine tumors it was found that necrotic regions are often well oxygenated
(Zeman et al. 1993), suggesting that other nutrient gradients may affect cell viability. We
recently developed a mathematical model that integrates the effects of oxygen and
glucose on tumor growth (Venkatasubramanian et al. 2006). This model predicted that
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although oxygen availability is the major factor governing cell viability, glucose supply
plays a large and almost equal role (Venkatasubramanian et al. 2006). Similarly,
experiments with cells lacking hypoxia inducible factor-1α, the primary oxygen-sensing
transcription factor, have shown that glucose gradients limit the ability of cells to respond
to low oxygen environments (Kim and Forbes 2007; Seagroves et al. 2001).

Cellular rearrangement, defined as the change in location of cells within tissue over time,
is an essential initial step in the metastatic spread of cancer cells from tumors (Kedrin et
al. 2008). To enter the blood stream cancer cells need to penetrate through surrounding
cancerous and normal tissue (Hanahan and Weinberg 2000; Wyckoff et al. 2000). In cell
culture, hypoxia has been shown to both stimulate (Krishnamachary et al. 2003; Ryu et
al. 2010) and repress (Ackerstaff et al. 2007) invasion into extracellular matrix. Hypoxia
affects invasiveness by regulating CXCR4 (Cronin et al. 2010; Marchesi et al. 2004) and
disabling the E-cadherin-catenin complex (Demir et al. 2009). Hypoxia has been shown
to enhance spreading of cells within spheroids onto surrounding cell monolayers
(Indovina et al. 2008). In spheroids, cells spontaneously rearrange, circulating from the
outside edge towards the center (Dorie et al. 1986; Dorie et al. 1982). Computational
models of tumor cords have suggested that varying oxygen concentrations can rearrange
cells by affecting growth and death rates (Bertuzzi A et al. 2004; Bertuzzi A et al. 2005).
Other mathematical models of cell rearrangement have suggested that nutrient gradients
could control cell migration (McElwain and Pettet 1993), but it has not been
demonstrated whether oxygen gradients alone can control these phenomena.
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Several cell culture techniques have been developed to investigate the effects of modified
oxygen gradients. Early methods to create in vitro oxygen gradients are the bubble
(Baracchini and Sherris 1959) and capillary (Engelmann 1881) assays, which were used
primarily to study microbial chemotaxis. More recently a perfusion bioreactor system has
been created that generates oxygen gradients over a monolayer of mammalian cells in a
flat-plate reactor (Allen and Bhatia 2003). Another system utilized a microfabricated
insert for multiwell plates to spatially and temporally modify oxygen gradients on cell
monolayers (Oppegard et al. 2009). Finally, 3D oxygen gradients have been created by
stacking layers of paper impregnated with cells in an extracellular matrix (Derda et al.
2009). While these systems all elegantly determined the effects of oxygen on individual
cells, none were designed to determine the effects of local oxygen gradients on cellular
viability and rearrangement in three-dimensional tumor tissue.

To understand the relationships between oxygenation, cell viability and cellular
rearrangement, we developed a micrometer-scale oxygen delivery device to create
precise oxygen gradients in three-dimensional tumor tissue. I hypothesized that oxygen
would reduce death and cause cells to rearrange in cylindroids. The device was designed
to deliver controlled doses of oxygen to scaffold-free three-dimensional tissue. It was
based on two techniques previously developed in our laboratories: a microsystem that
patterns oxidative microgradients (Park et al. 2006) and multicellular tumor cylindroids
(Kasinskas and Forbes 2006; Kim and Forbes 2008), an in vitro culture technique that
creates microenvironments similar to those in tumors. The principal design goal was to
create a device that could deliver oxygen to the necrotic center of cylindroids. This
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geometry would invert oxygen gradients while maintaining all other nutrient gradients,
and would enable straightforward modeling of the results. After fabrication, the device
was tested by supplying oxygen to tissue composed of colon carcinoma cells.
Fluorescence staining was used to determine the magnitude and location of cell death,
and a mathematical model was used to determine the sensitivity of growth and death to
oxygen. Results obtained with the device show that oxygen is a primary factor controlling
cell viability and rearrangement in three-dimensional tissue.

1.2 The effects of surface charge of gold nanoparticles on doxorubicin delivery
Inefficient delivery limits the efficacy of many chemotherapeutic treatments (Lankelma
et al. 1999; Minchinton and Tannock 2006). Overcoming delivery limitations requires
precise control of interstitial diffusion and cellular uptake. Tumors typically have
irregularly formed vasculature with large intervessel distances and heterogeneous
populations of cells (Vaupel et al. 1989). These populations are often unresponsive to
standard therapy because of their distance from blood vessels and resistance to molecular
uptake. This limited efficacy prevents complete cell clearance per drug cycle, which can
eventually lead to tumor regrowth, metastatic disease, and poor treatment outcomes
(Grantab et al. 2006).

Colloidal gold nanoparticles have great potential to overcome delivery limitations
because of their biocompatibility, low toxicity, small size, and tunable surface
functionalities (You et al. 2005). Functionality can be tuned by modifying the
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composition of functional molecules in the mixed monolayer on the surface of gold
nanoparticles (Goodman et al. 2006; McIntosh et al. 2001). In cancer cell cultures,
surface properties have been shown to regulate cellular uptake, intracellular release, and
distribution in subcellular compartments (Rosi et al. 2006; Thomas and Klibanov 2003).
Modification of the surface properties of gold nanoparticles therefore has the potential to
control accumulation in tumors, and where drug payloads are released.

The cellular uptake and dissociation of fluorescein isothiocyanate (FITC) from
fluorescein-loaded gold nanoparticles (FITC-AuNP) were shown to be greater for
cationic gold nanoparticles (p-FITC-AuNP) as compared to anionic gold nanoparticles
(n-FITC-AuNP), previously by the Forbes lab. Based on this observation, I hypothesized
that cationic nanoparticles would be more efficient in delivering the chemotherapeutic
drug doxorubicin to tumor cylindroids. A set of positive and negative particles (DOXAuNP) was synthesized with monolayers consisting of thioalkylated doxorubicin (DOXSH) and TTMA or TCOOH (Fig. 2.1). Previous work also suggested that
apoptotic/necrotic cells had a higher rate of uptake of FITC compared to live cells.
However, there was no direct experimental evidence. To address these objectives, cells
on monolayer as well as tumor cylindroids were treated with the nanoparticles and timelapse fluorescence microscopy was used to monitor uptake of doxorubicin.
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1.3 Development of a continuously perfused tumor tissue model
The systemic clearance of drugs by metabolism, excretion, and uptake by tissues is an
important mechanism and an integral step involved in the delivery of any therapeutic
agent. Several in vitro models have been developed with the idea of testing cancer
therapies and reducing animal testing of drugs (Elliott and Yuan 2011). These models fail
to incorporate the important phenomenon of drug clearance.

The multicellular spheroid model was first developed by Sutherland (Sutherland and
Durand 1976) and mimicked heterogeneous tumor microenvironments well. They
contained proliferating, quiescent, and necrotic regions as found in tumors. The
cylindroid model, based on the spheroid model, was developed by the Forbes lab (Kim et
al. ; Kim and Forbes 2008). This model facilitated microscopy of spheroids by providing
access to the entire cross section, while maintaining heterogeneous microenvironments.
The hollow-fiber model was developed for screening cancer drugs and contained cancer
cells packed into biocompatible fibers made of polyvinylidine fluoride (Casciari et al.
1994). The multicellular layer was developed by Cowan (Cowan et al. 1996) for the
direct measurement of the diffusion of drugs in tissues. All these models mimicked
heterogeneous tumor microenvironments and drug delivery, but not clearance. Recently,
there have been a few efforts to culture three-dimensional tissues in continuously
perfused devices (Toh et al. 2007; Wu et al. 2008).

In this dissertation, I describe the development of a microfluidic tumor tissue culture
device that contained rectangular chambers for housing tumor tissues. Devices were
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designed out of glass and a transparent polymer to enable microscopy. Rectangular shape
of the tissue simplified mathematical analysis to linear coordinates. The design and
operation of the devices were optimized to enable tissue culture for up to 3 days and to
allow introducing multiple tissues into one device. In vitro devices that mimic tumor
microenvironments, drug diffusion, and systemic clearance more accurately capture the
mechanisms of drug delivery and can help screen for drugs more efficiently.

1.4 The effects of motility on bacterial distribution in tumors
Bacterial cancer therapies have the ability to overcome some of the fundamental
limitations of cancer chemotherapies, but the role of motility in bacterial penetration into
tumors is not clearly understood. Chemotherapeutics are limited by passive diffusion into
solid tumors and fail to reach all parts of tumors in sufficient concentrations (Cowan and
Tannock 2001; Davis and Tannock 2002; Minchinton and Tannock 2006; Tannock
2001). Bacteria can penetrate deeper into tumors and accumulate at higher concentrations
because of their ability to actively migrate (Kasinskas and Forbes 2006; Kasinskas and
Forbes 2007) and replicate in favorable environments (Alexandre et al. 2004). In animal
models, several genera of bacteria have been shown to preferentially accumulate in
tumors compared to other organs (Barnett et al. 2005; Forbes et al. 2003a; Kohwi et al.
1978; Min et al. 2008; Parker et al. 1947; Pawelek et al. 1997; Yu et al. 2004) with
greater than 1000-fold selectivity. This accumulation led to tumor shrinkage and
enhanced survival (Nagakura et al. 2009). Bacteria have also been engineered to express
anticancer agents for targeted delivery to tumors (Forbes 2010; Ganai et al. 2009;
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Pawelek et al. 1997). Salmonella typhimurium, strains SL1344 (Stritzker et al. 2007) and
VNP20009 (Forbes et al. 2003a; Low et al. 1999; Pawelek et al. 1997), and Escherichia
coli, strains K12 (Weibel et al. 2008) and DH5α (Zhang et al.), are facultative anaerobic
enteric bacteria with well-studied and easily modifiable genetics that have previously
been evaluated as anti-cancer therapies.

To clarify the role of motility there is significant need to quantify the spatiotemporal
dynamics of the accumulation of highly and minimally motile bacterial strains in tumor
tissue. For bacteria to be effective cancer therapeutics, it is necessary that they penetrate
deep into tissue and colonize homogeneously throughout tumors (Westphal et al. 2008).
It has been shown that bacteria that can better disperse throughout tumors have an
increased ability to regress tumors (Dang et al. 2001). However, bacterial accumulation
in tumors is known to be spatially heterogeneous and often restricted to necrotic regions
(Dang et al. 2001; Forbes et al. 2003a). In addition, Salmonella chemotax towards
chemicals produced in the necrotic regions of tumors (Kasinskas and Forbes 2006;
Kasinskas and Forbes 2007). An attenuated non-pathogenic strain of Salmonella
(VNP20009) was tested in three Phase-1 clinical trials and found to only colonize tumors
in a fraction of patients and not slow tumor growth (Heimann and Rosenberg 2003;
Nemunaitis et al. 2003; Toso et al. 2002). In one clinical trial, a tumor excised from a
patient showed 11,000 CFU/g-tumor bacterial accumulation, but a fine needle aspirate
drawn from the same tumor showed no accumulation (Toso et al. 2002), suggesting that
the bacterial accumulation within the tumor was spatially heterogeneous. Because there
was no reduction in tumor size reported in these studies, the extent of bacterial
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accumulation was insufficient. To overcome these limitations, it is necessary to
understand the mechanisms that control bacterial spreading and accumulation in tumors.

Two mechanisms have been proposed as significant causes of bacterial tumor
colonization and subsequent spreading: motility and preferential growth within the tumor
microenvironment (Min et al. 2008; St Jean et al. 2008; Zhao et al. 2005). Motility is
widely accepted as a virulence factor for pathogenic organisms (Eaton et al. 1989; Moens
and Vanderleyden 1996; Ottemann and Miller 1997) and is necessary for bacterial
penetration into host tissues (Eaton et al. 1992; Lux et al. 2001). Motile Salmonella have
been shown to migrate away from functional vasculature in tumors, where they form
colonies and delay tumor growth (Ganai et al. 2011). The mechanisms that enable
bacteria to initially cross the endothelium are unknown (Forbes et al. 2003b), but several
experiments have demonstrated that bacteria colonize tumor interstitium outside blood
vessels (Forbes et al. 2003b; Ganai et al. 2011). Colonization and spreading have also
been studied in porous media. These systems are analogous to tumors where the walls of
the medium correspond to cell membranes in the tissue. In porous media, motile bacteria
penetrate better than non motile bacteria (Sherwood et al. 2003) and differences in
motilities between different strains give rise to different diffusive behaviors (Olson et al.
2005). Reports about the role of motility in bacterial penetration and accumulation in
tumors, however, have been contradictory. It has been shown for some bacterial strains
that the extent of bacterial accumulation in tumors is independent of motility (Crull et al.
; Stritzker et al.). Some non-motile bacteria have been shown to have better transport
properties through porous surfaces than motile bacteria (Becker et al. 2003), possibly
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because of lesser probability of collision with pore surfaces (Becker et al. 2003; Liu et
al.). Bacteria have also been shown to penetrate into narrow constrictions, independent of
motility, by means of growth and division alone (Mannik et al. 2009).

Bacteria naturally have a therapeutic effect on tumors. Native toxicity of bacteria
regresses tumors (Low et al. 1999; Nagakura et al. 2009; Pawelek et al. 1997; Theys et al.
2006; Weibel et al. 2008) and bacteria have also been used to express anticancer agents
(Gentschev et al. 2005; Jiang et al. ; Loeffler et al. 2007). Native toxicity has been
attributed to competition for nutrients and sensitization of the host immune system (Sznol
et al. 2000). At low densities, invasive Salmonella have no intrinsic toxicity to tumor
cells in vitro (Avogadri et al. 2005). However, Salmonella colonization in tumors causes
apoptosis both in vitro (Kasinskas and Forbes 2007) and in vivo (Ganai et al. ; Pawelek et
al. 1997).

To measure the spatiotemporal dynamics of bacterial accumulation and induced
apoptosis, I developed an in vitro model of continuously perfused tumor tissue (Toley et
al. 2011; Walsh et al. 2009). I hypothesized that 1) strains with higher motility have
enhanced penetration and colonization, and 2) the location of bacterial colonization
within tissue corresponds to the location of apoptosis. To test these hypotheses, the
motility of four strains, Salmonella (SL1344 and VNP20009) and E.coli (K12 and
DH5α), was measured in aqueous solution. The four stains were introduced into tissue
and the location of colonization and induced apoptosis was measured over time with
fluorescence microscopy. A mathematical model was used to determine the relative
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contribution of dispersion and growth, and predict behavior around blood vessels in
tumors. Understanding the role of bacterial motility in tumor penetration, spreading, and
apoptosis induction will be critical for designing effective bacterial therapies.

1.5 The effects of transport and binding on drug efficacy
Intratumor transport and binding are important mechanisms governing a drug’s efficacy,
yet these factors are not systematically quantified during drug development. Cancer drug
development starts with testing a large library of compounds on monolayers of cancer
cells (Grever et al. 1992; Shoemaker 2006). Compounds that are most cytotoxic are
selected and tested in mice xenograft models for their ability to shrink tumors (Plowman
et al. 1997). Only a small percentage of compounds tested in xenograft models
successfully regress tumors. We compiled results from two separate studies in which 12
potential anticancer agents were tested on human breast cancer cells MDA-MB-435,
grown as monolayers (data obtained from the NCI Screening Services), or implanted as
xenografts in mice (Plowman et al. 1997). There was no correlation (R2 = 0.01) between
the cytotoxicity of compounds in monolayers and their ability to regress tumors in mice
(Fig. 1.1). Cytotoxicity is not a viable indicator of a drug’s therapeutic effect.

Several transport processes and reactions occur when a chemotherapeutic drug is
intravenously administered. Immediately after delivery, the plasma concentration of the
drug is at its zenith. In time, the concentration decreases as a result of metabolism,
excretion, and uptake by various tissues (Lin and Lu 1997). During this period, the drug
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enters tumors (Fig. 1.2A). After plasma drug level falls below tumor drug level, a reverse
flux initiates causing drug clearance from the tumor (Fig. 1.2A). The presence of drug in
the tumor causes cell death at a rate related to its concentration. Certain drugs may
reversibly or irreversibly bind (Bryn and Dolch 1978; Lankelma 2002) to specific sites
within the tumor (Fig. 1.2A). Binding can significantly increase residence time in tumors
and enhance therapeutic effect. The anticancer ability of chemotherapeutics like
doxorubicin and daunorubicin has been attributed to their strong ability to intercalate
DNA (Sartiano et al. 1979). The therapeutic effect of drugs is therefore the result of a
complex interaction of transport processes and reactions. Rapid plasma clearance and
limited diffusion into tumors, for example, have been shown to significantly limit the
efficacy of several cancer drugs (Minchinton and Tannock 2006). Current monolayer
based methods used for screening drugs overlook this complex set of interactions. To
date, there are no existing methods that can measure the diffusion, binding, and long-term
retention of drugs in tumor tissue.

Pharmacokinetic/pharmacodynamic (PK/PD) models are used extensively in drug
development to measure and predict the time course of a drug’s therapeutic effect
(Derendorf et al. 2000; Gabrielsson and Green 2009). Pharmacokinetics (PK) measures
the concentration of drugs in the body as a function of time. Pharmacodynamics (PD)
measures the rate and extent of the antitumor effect induced by the drug as a function of
drug concentration. Current PK/PD models simplify reality by assuming that plasma and
tissue are well-mixed compartments. For a long time, PK/PD models assumed that the
concentration of drug in tissue was in equilibrium with the plasma concentration,
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disregarding the kinetics of tissue distribution (Derendorf and Meibohm 1999). The
limitations of this approach were recognized and new approaches, where an additional
well-mixed compartment was introduced between plasma and tissue, were later
developed (Hochhaus et al. 1992; Kramer et al. 1979; Sheiner et al. 1979). These models
better predicted the delay between PK effects in plasma and PD effects in tissue.
Although they improve representation of reality, such models are still simplified and
disregard the mechanisms of tissue drug distribution. Solid tumors are known to present
barriers to the transport of drugs (Jain 1994; Tredan et al. 2007). In order to more
accurately predict tissue drug concentrations and therapeutic effects, PK/PD models must
integrate transport processes that govern drug distribution in tumors.

Many chemotherapeutic drugs suffer from limited therapeutic accumulation in tumors
(Jain 1998) and harmful effects and toxicity to other organs in the body (Curigliano et
al.). Encapsulation of drugs in colloidal particles like liposomes is a potential method of
overcoming these limitations. Poly-(ethylene glycol) (PEG) coated liposomes (stealth
liposomes) are biocompatible, non-toxic, and have a reduced uptake by the mononuclear
phagocyte system, resulting in significantly long plasma circulation times (Immordino et
al. 2006). Doxorubicin encapsulated in stealth liposomes, Doxil, has gained FDA
approval for the treatment of AIDS-related Kaposi’s sarcoma, ovarian cancer, and
multiple myeloma, and has been shown to reduce cardiac toxicity (Immordino et al.
2006). Several other cancer drugs encapsulated in stealth liposomes are currently in
advanced stage clinical trials (Farhat et al. 2011; Seetharamu et al. 2010; Zamboni et al.
2009). Improving pharmacokinetics by liposome encapsulation, however, comes at the
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cost of limited drug release at the tumor site. To be effective, a liposome-encapsulated
drug must dislodge into the tumor interstitial fluid and release its payload. The release of
drug from stealth liposomes is known to be very gradual (Harrington et al. 2000) and the
mechanisms of drug release are not well understood (Gabizon 2001; Immordino et al.
2006). Another chemotherapeutic agent, cisplatin, encapsulated in stealth liposomes (SPI077), and a variant stealth liposome (SPI-077 B103) designed specifically to increase the
rate of cisplatin release, were both reported to have minimal drug release in mice
melanoma tumors (Zamboni et al. 2004). SPI-077 was found to have no therapeutic
efficacy in Phase I/II clinical trials, despite a long circulation time (Harrington et al.
2001). Intratumoral drug release from liposomes is an important mechanism that
determines the efficacy of liposome-encapsulated drugs.

To enable simultaneous measurement of drug diffusion, binding, and intratumor drug
release from liposomes, I developed an in-vitro model of continuously perfused tumor
tissue (Toley et al. 2011) that mimicked the delivery and clearance (PK) of drugs (Fig.
1.2B). Tumors tissues were treated with doxorubicin and Doxil, model free and
liposome-encapsulated drugs, for a fixed period of time followed by clearance. The
spatiotemporal location of the two drugs was measured by fluorescence microscopy. To
decouple the contribution of individual mechanisms towards tissue drug distribution, I
developed a mathematical model that incorporated tissue-level transport and binding, as
well as pharmacokinetics and pharmacodynamics – the ‘PK/PD-Transport-Reaction’
model. This model was extended to account for liposome encapsulation of drugs. Results
from the model were used with experimental data to evaluate key parameters governing
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the therapeutic efficacy of the two drugs. Measuring the tissue distribution, binding, and
the rate of intratumor drug release from carriers like liposomes is of immense
significance and will enable designing better cancer therapies.
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Figure 1.1 Therapeutic response in monolayers and xenografts. Compilation of results
from the treatment of MDA-MB-435 breast cancer cells grown as monolayers (hollow
squares) or implanted in mice as xenografts (black bars), with 12 chemotherapeutic
agents. There was no correlation (R2 = 0.01) between monolayer cytotoxicity and
therapeutic response in mice. Chemotherapeutic agents used were actinomycin D (ActD),
vinblastine (VBL),
doxorubicin (ADR), paclitaxel (PAC), Cisplatin (DDPt),
methotrexate (MTX), bleomycin (BLEO), 5-fluorouracil (5-FU), melphalan (L-PAM),
cytoxan (CYT), and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
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Figure 1.2 Intratumor transport and binding. A: Intravenously injected chemotherapeutic
drugs diffuse into tumors and bind to certain targets. After systemic clearance, drugs
diffuse out of tumors. Binding plays an important role in determining the rate of drug
clearance from tissue. Monolayers of cancer cells do not capture these complex
mechanisms. B: The microfluidic perfusion device designed to measure transport of
drugs in tumors mimics the delivery and clearance of drugs and captures all these
important mechanisms.

21	
  

CHAPTER 2
MATERIALS AND METHODS

2.1 The effects of modified oxygen gradients on tumors
2.1.1 Design of the micrometer-scale oxygen delivery device
The device was designed to produce localized oxygen at the center of cylindroids. An
iterative design process was used to integrate the oxygen generation chip (Park et al.
2006) with cylindroid culture (Kasinskas and Forbes 2006; Kim and Forbes 2007; Kim
and Forbes 2008). All electrolysis chip devices consisted of 10 µm diameter circular
microelectrodes patterned over a glass substrate and covered with a gas permeable
polydimethylsiloxane (PDMS) microchannel (Fig. 2.1A). The roof of the microchannel
acted as a barrier membrane between the electrolysis chamber and the cell culture area.
The cathode had a large surface area to minimize hydrogen flux and was placed far from
the anode to prevent interaction of hydrogen with tissues (Fig. 2.1C). After fabrication,
the oxygen generation chips were attached to the bottom of 48 well plates (Fig. 2.1A).
Dissolved oxygen generated at the anode diffused through the electrolyte and PDMS
film, and into the cell culture area (Fig. 2.1A). To create a functioning tumor oxygenation
device several features were tuned, including the thickness of the PDMS layer, the height
of the electrolyte channel, the design of the channel, the method of cylindroid insertion
into the device, and the design of the cell chamber.
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2.1.2 Monolayer, spheroid and cylindroid cultures
Human colorectal adenocarcinoma LS174T cells obtained from ATCC (Manassas, VA)
were grown on T75 flasks in low glucose (1 g/L) Dulbecco’s Modified Eagle’s Medium
(DMEM; Sigma-Aldrich, St. Louis, MO), and supplemented with 10% fetal bovine
serum. Spheroids were made by inoculating single cell suspensions at 2.5 x 104 cells/ml
onto poly(2-hydroxyethyl methacrylate) coated T25 culture flasks. Cylindroids (125 ± 20
µm thick) were formed by constraining spheroids between culture surfaces and
polycarbonate plugs (Fig. 2.1B) as described previously (Kasinskas and Forbes, 2006),
and submerged under 200 µl culture medium. All cultures were incubated at 37˚C, pH
7.4, in 5% CO2 in ambient air, with 100% humidity.

2.1.3 Cylindroid positioning
For controlled localized delivery of oxygen, accurate positioning of cylindroids over the
anode was necessary. A micro-positioner was designed that consisted of a polycarbonate
cylindrical plug (3 mm in diameter) attached to a rectangular head, which was suspended
on a base by four screws (Fig. 2.1D). A 3 µl medium droplet containing a single spheroid
was placed on the tip of the positioner plug, and introduced into the well plate. The X and
Y coordinates of the tip were adjusted by moving the plug manually; the Z coordinate,
which controlled thickness of the cylindroid, was adjusted with the four screws (Fig.
2.1D).
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2.1.4 Visualization of electrolytically generated oxygen
Operation of the oxygen-generating electrode was confirmed by supplying an electrolysis
current great enough to form a gas bubble at the anode. An electrolysis current of 10 µA
was supplied for 6 seconds to generate more oxygen than the solubility limit in water.
The size of the bubble formed was measured as a function of time using ImageJ (NIH
Research Services Branch). For experiments involving cylindroids, a 100-fold lower
current was used that did not lead to bubble formation.

2.1.5 Estimation of maximum growth rate
The growth rate of LS174T cells was determined by growing a monolayer of cells on a
well plate under ambient oxygen conditions. Cells were plated at a density of 25,000/cm2
on a 48 well plate and images were acquired at 10, 17.5, 25 and 32.5 hours. These cells
are highly coherent and form clumps on culture surfaces, preventing direct cell counting.
Cell densities were determined at each time point by measuring the total area occupied by
the cells (n=3). Maximum growth rate, µgmax, was estimated by fitting cell areas to an
exponential growth rate expression.

2.1.6 Oxygen microgradients within cylindroids
Two groups of cylindroids were investigated: an oxygenated group and a control group
that did not receive oxygen. After positioning, oxygenated cylindroids were incubated for
60 hours with a fixed electrolysis DC current generated with a Keithley 2400 Series
supply (Keithley, Cleveland, OH). Deionized water was used as the electrolyte. The
applied electrolysis current of 0.1 µA produced a theoretical dissolved oxygen flux of 3.3
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x 10-3 mol·m-2·s-1 from the anode, assuming 100% electrolytic efficiency. We have
previously shown with a similar device that most of an applied current produces
molecular oxygen and that the production of reactive oxygen species is minimal (Park et
al. 2006). Control cylindroids were incubated in absence of electrolysis current.

2.1.7 Quantification of cell death in cylindroids
Ethidium homodimer (Eth-D1; Invitrogen, Carlsbad, CA) selectively stains cells with
permeable membranes and was used to determine the extent of cell death in cylindroids.
After 48 hours of cylindroid preparation, existing medium was replaced with fresh
medium containing 4 µM Eth-D1. Fluorescent images were acquired 12 hours after
addition of the stain using an Olympus (Center Valley, PA) IX71 inverted epifluorescent
microscope equipped with a color-corrected 10x Plan-APO and a 20x LCPlanFI
fluorescence objectives, respectively, and IPLab (BD Bioscience, Rockville, MD)
software. For large cylindroids that exceeded the bounds of a single camera frame
(867.15µm x 660.68µm), a 2x2 grid of images was acquired at 10x magnification in a
single focal plane. One tiled image of the cylindroid was formed by stitching the four
pieces together using a macro in IPLab. Red fluorescence images were acquired using
546/10 nm excitation and a 590 nm long pass emission filter (Chroma, Rockingham, VT).

The extent of cell death in cylindroids was quantified using normalized radial intensity
profiles of Eth-D1 fluorescence obtained using ImageJ (NIH Research Services Branch).
For each cylindroid, average fluorescence intensity of five visually identified dead cells
was used to define maximum (100%) death; average intensity of five viable cells was
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used to define minimum (0%) death. A linear interpolation between these two points
related Eth-D1 fluorescence intensities to extent of cell death.

2.1.8 Cell rearrangement in cylindroids
Rearrangement of dead cells in a cylindroid was observed by staining with Eth-D1.
Fluorescent and transmitted light images were acquired every 20 minutes for a period of
16 hours. To observe individual cells over the entire cylindroid, a grid of 3x3 images
(433.58µm x 330.34µm) was acquired at 20x magnification in a single focal plane at each
time point and tiled using IPLab. Cells within the cylindroid were tracked in time, and
distances from the center of the cylindroid were estimated. The distances were
normalized by the current radius of the cylindroid to account for growth, and
renormalized by the starting locations of each cell to quantify movement of cells relative
to their starting positions.

2.1.9 Steady-state mathematical model of three-dimensional oxygen profiles
Two distinct modeling techniques were used to analyze oxygen delivery and cell
viability. The first technique determined three-dimensional oxygen profiles in cylindroids
based on an applied electrode current. The second one-dimensional modeling technique
analyzed cell viability in the presence and absence of oxygen delivery. The second model
utilized the resulting oxygen profiles from the first model as inputs. It was necessary to
maintain three dimensions in the first model to account for oxygen in the culture medium
surrounding the outer edge of the cylindroid (Fig. 2.1A).
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The steady-state oxygen profile model determined oxygen profiles in cylindroids based
on the molecular transport equation, which balanced oxygen diffusion with cellular
uptake.

Di∇ 2C =

R maxC
Km + C

(1)

where C is the local oxygen concentration; Di is the diffusivity of oxygen in electrolyte,

€

PDMS, or cylindroid; Rmax is the maximum oxygen uptake rate; and Km is the saturation
constant (Table 2.1). This model was solved using Comsol Multiphysics (Comsol,
Burlington, MA). The model (see Fig. 2.1A) accounted for oxygen generation at the
electrode, consumption by cells within the cylindroid, and diffusion through the
electrolyte (5 µm thick), the PDMS (10 µm thick) and into the cylindroid (125 µm thick).

A three-dimensional domain was created in Comsol Multiphysics that contained three
cylindrical layers. The bottom layer was the electrolyte (5 µm thick), the intermediate
layer was PDMS (10 µm thick), and the top layer was the cylindroid (125 µm thick). The
diameters of the bottom layers were set to 1000 µm and the diameter of the cylindroid
was set to 500 µm. Oxygen delivery from the surrounding medium was accounted for by
maintaining a constant concentration at the cylindroid boundary. Oxygen generation at
the anode (10 µm diameter) was dependent on the applied current (3.3 x 10-2 mol·m-2·s1

·µA-1), and was set as a known flux boundary condition over a central 10 µm diameter

circular region on the bottom layer of the electrolyte. In the electrolyte and PDMS
oxygen uptake was set to zero. In the cylindroid the uptake rate was dependent on the
local oxygen concentration, C, the maximum uptake rate, Rmax, and the saturation
constant, Km.
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2.1.10 Dynamic model of cell growth and death
A dynamic model was used to determine the effect of oxygen on cell growth and death.
This model is based on a spheroid growth model created previously in our laboratory
(Venkatasubramanian et al. 2006) and consists of three coupled partial differential
equations.

∂L
+ ∇ ⋅ (vL) = ( µ g − µd ) L
∂t

(2)

∇ ⋅ v = µ g LVL − µd L(VL − VD )

(3)

Dox ∇ 2C =

R maxC
L − Qgen
Km + C

(4)

The first equation (Eq. 2) is a live cell population balance that accounts for growth, µg,

€

death, µd, and convective supply of live cells due to tissue expansion, ∇ ⋅ (vL) . The
number density of live cells, L, is defined as the number of live cells per single cell
volume (0 < L < 1). The second equation (Eq. 3) accounts for tissue expansion and
contraction as cells grow, µgLVL, and die, µdL(VL-VD), where v is the convective velocity
and VL and VD are single cell volumes of live and dead cells (Table 2.1). This balance
assumes that the entire volume was occupied by either live or dead cells. The third
balance (Eq. 4) accounts for oxygen diffusion in the cylindroid, Dox; cellular uptake (as
described above); and generation of oxygen by the electrode, Qgen. Oxygen generation
was modeled with an empirical Hill-like function, in which the rate varied as a function
of cylindroid radius, r.

⎛
r a ⎞
Qgen = Qmax ⎜1 − a a ⎟
⎝ r + rc ⎠

(5)

28	
  

The parameters, rc and a, were adjusted until the oxygen profile in the cylindroid
matched the profile calculated by the steady state three-dimensional oxygen model (Eq.
1). This matching was necessary to integrate the three-dimensional profile results into the
one-dimensional cell balance model. The density of dead cells, D, was calculated from
the live cell density, L.
(6)

VL L + VD D = 1

The rates of cell growth, µg, and death, µd, were assumed to be dependent on the
available oxygen level, C.

µg =

µ gmax C
K g ,ox + C

;

⎛
⎞
C
µd = µdmax ⎜⎜1 −
⎟⎟
⎝ K d ,ox + C ⎠

(7)

The growth and death saturation constants, Kg,ox and Kd,ox, represent the sensitivity of the
rates to oxygen availability. The maximum growth rate, µ gmax , i.e. growth in the absence
of nutrient limitations, was determined experimentally as described above. The model
assumes that the effects of extracellular matrix (Ambrosi and Preziosi 2009) and cellular
mechanical properties (Ambrosi and Preziosi 2009) were uniform across cylindroids, and
that the effects of anaerobic glucose metabolism (Gatenby and Gawlinski 1996;
Smallbone et al. 2007) were minimal. Values of the maximum rate of cell death, µdmax,
and the saturation constants, Kg,ox and Kd,ox, were determined by fitting the model to the
viability profiles.

Simulations were run for each combination of physiological parameter values and least
squares optimization was used to determine which simulation result best fit the observed
radial cell death profiles. Simulations were performed by discretizing equations (2-4)
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using orthogonal collocation on finite elements. The resulting set of differential algebraic
equations (DAE) was solved using the ode15s solver in Matlab (The Mathworks, Inc.
Natick, MA). All growth simulations were initialized with a cylindroid consisting of a
single 11 µm radius live cell and continued without oxygen supply until they reached a
pre-specified intermediate size. This size was adjusted to generate cylindroids with final
radii matching the experimental cylindroids. Once the simulated cylindroids reached the
pre-specified intermediate size, oxygen was supplied to the oxygenated group for 60
hours. Control simulations did not receive oxygen.

2.2 The effects of surface charge of gold nanoparticles on doxorubicin delivery
2.2.1 Cell Culture
Human colorectal adenocarcinoma LS174T cells were obtained from ATCC (Manassas,
VA) and grown as described in section 2.1.2.

2.2.2 Spheroid and Cylindroid Cultures
Spheroids and cylindroids were used as models of 3D tumor tissue. Their formation and
maintenance was as described in section 2.1.2.

2.2.3 Image Acquisition
All cylindroid images were acquired as described in section 2.1.7 after extending the
IPLab routine to capture tiled images of multiple cylindroids every 2 hours. Images of
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monolayers were acquired every 2 hours using a 20x LCPlanFL fluorescence objective,
using another IPLab routine.

2.2.4 Dox-AuNP uptake in monolayers
Human colon carcinoma LS174T cells were plated on a standard 48-well culture plate
and incubated for 16 hours. After incubation, cells were washed with saline three times
and treated with HEPES buffered medium (viable cells) or saline (dead cells) containing
500 nM positive Dox-AuNP, 500 nM

negative Dox-AuNP or 800 nM Ethidium

Homodimer (Eth-D1) (Invitrogen, Carlsbad, CA). Eth-D1 is a cell membrane impermeant
fluorescent dye that undergoes a 40-fold enhancement in fluorescence when bound to
nucleic acids. It was used to distinguish between viable and dead cells because it
selectively enters cells with compromised cell membranes (dead cells). After treatment,
cells were maintained in a temperature controlled environment at 37°C on a microscope
for time-lapse acquisition of transmitted and red fluorescent images. Three locations per
well were analyzed for fluorescence. The increase in fluorescence intensities from 1 hour
to 17 hours post treatment was evaluated for each location.

2.2.5 Dox-AuNP uptake in cylindroids
Cylindroids were prepared and incubated for 18 hours. After incubation, they were
treated with HEPES buffered medium containing 1 µM positive Dox-AuNP, 1 µM
negative Dox-AuNP and 1 µM Dox (Sigma Aldrich, St. Louis, MO) and maintained in a
temperature controlled environment at 37°C on a microscope for time lapse acquisition of
transmitted and fluorescent images.
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2.2.6 Normalized Radial Intensity Profiles
Pixel based radial intensity profiles were obtained from fluorescent images of cylindroids
using a customized script (ImageJ, NIH Research Services Branch). Cylindroid
boundaries were defined by circles, and intensity values over annuli at each radial
location were averaged to return radial intensity profiles. Distances were normalized by
radii of corresponding cylindroids, which changed with time. To get radial intensity
profile vectors of consistent lengths, all radii were divided into 20 equal intervals and the
intensities over each interval were averaged. For each cylindroid, the initial radial
intensity profile was subtracted from all further time points, to obtain profiles of increase
in radial intensity over time.

2.3 Fabrication, operation, and optimization of microfluidic devices for continuous
tumor tissue culture
2.3.1 Photomasks
Microfluidic devices were fabricated using soft lithography (Duffy D. C. 1998; Toley et
al. 2011). The first step in this process is creating photomasks. Desired features were
drawn electronically in Adobe Illustrator (Adobe Systems Incorporated, San Jose, CA).
To form photomasks, the designs were printed on a high-quality 100 µm polyester-based
Imagesetting film using an emulsion-based process (PageWorks, Cambridge, MA).
Negative prints, where desired features were transparent and the rest of the film black,
were obtained (Fig. 2.2).
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2.3.2 Mold fabrication
Molds for devices were made on 100 mm silicon wafers (WaferWorld, West Palm Beach,
FL). Light sensitive polymer SU-8 (MicroChem, Newton, MA) was spin coated on
silicon wafers to obtain a 150 µm layer. A two-step spin cycle was used – Step 1: 500
rpm for 10 seconds at an acceleration of 100 rpm/s, Step 2: 1250 rpm for 30 seconds at an
acceleration of 300 rpm/s. This was followed by a series of baking steps on a slide
warmer - 65°C for 5 minutes, room temperature for 10 minutes, followed by 95°C for 30
minutes. The wafers were exposed to 260 mJ/cm2 ultraviolet light through the
photomasks to selectively cure features on SU-8. This was followed by another series of
baking steps - 65°C for 5 minutes, room temperature for 10 minutes, and 95°C for 12
minutes. After cooling, these wafers were submerged in SU-8 developer (MicroChem,
Newton, MA) and mildly agitated for 10 minutes. Uncured SU-8 dissolved, which
formed positive relief features on silicon wafers. A brief conceptual schematic is
provided in Fig. 2.3A.

2.3.3 Replication of molds
Molds were replicated using the Sylgard® 184 Silicone Elastomer Kit (Dow Corning,
Midland, MI). Elastomer base (composed of polydimethylsiloxane, PDMS) and
elastomer curing agent were mixed in a 9:1 ratio. The recommended ratio provided by
manufacturer is 10:1. I used a higher concentration of curing agent to make stiffer
devices that enable easier inlet and outlet hole punching. The mixture was vortexed for
60 seconds and poured over the mold. To remove air bubbles, the mold was placed in a
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vacuum chamber for 3 minutes. The mold was placed on a heating plate at 65°C
overnight for curing. A brief conceptual schematic is provided in Fig. 2.3B

2.3.4 Making holes for tubing connection
For connecting tubing for inlet and outlets, holes were made in the PDMS replicates (Fig.
2.4A,B). Several different methods were used. Initially, drilling and punching were used.
A ‘punch-drilling’ method was developed that involved drilling holes with a fast rotating
piece of beveled hollow metal tubing. Another method used was involved using a 1.5 mm
biopsy punches (Miltex, York, PA). Biopsy punches were mounted on a drill press.
Location of holes was marked on the PDMS replicates and the replicates were positioned
on the drill press. Biopsy punches were inserted into the PDMS gradually. Cleanliness
and dust-free state was maintained by protecting the features on the PDMS by clingwrap.

2.3.5 Bonding devices to substrate
Two different methods of bonding PDMS replicates to substrate were used (Fig. 2.4B,C).
The first method, ‘ratio mismatch bonding’, involved bringing 2 surfaces of PDMS with
different concentrations of curing agent – one partially cured and the other fully cured –
in contact with each other. A 100 mm diameter plastic culture dish (Fisher Scientific) was
used as the base. 10g of PDMS was mixed with 0.66g of the curing agent (15:1 PDMS:
curing agent) and poured onto the dish forming a thin layer over it. After removal of
bubbles by degassing, this layer was cured at 60°C for 45-60 minutes forming a partially
cured sticky polymer layer. A fully cured, thick layer of PDMS (9:1 PDMS: curing
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agent), already punched for inlets and outlets, was brought in contact with this partially
cured layer (features first), and the system was further baked at 60°C overnight. This
allowed a strong bond to form in between two PDMS layers.

Oxygen plasma treatment was the other method used to bond PDMS to glass. A PDMS
replicate with the features exposed and a glass slide were places in an oxygen plasma
etcher and treated for 8 minutes. After treatment, the features side of the replicate and the
treated side of the glass slide were brought in contact. Care was taken to remove any air
gaps. The device was places on a hot plate at 65°C under mild pressure overnight.

2.3.6 Connecting tubing to devices
PTFE tubing, 0.032” ID (Cole Parmer, Vernon Hills, IL), was connected to the inlets and
outlets for fluid flow and introducing tissue (Fig. 2.4D). In the initial stages of the
development of these devices, connecting tubing to devices and avoiding fluid leakage
was a challenge. Several methods were attempted. Initial methods included a) inserting
tubing into PDMS while it cured and b) inserting blunt syringe needles (Integrated
Dispensing Solutions, Agoura Hills, CA) into holes made in PDMS. Later, tubing was
attached to devices using an interface of male luer-lock connectors attached to barbed
female luer lock connectors (Qosina, Edgewood, NY), inserted into holes made in the
PDMS replicates. In the last method used, tubing was inserted directly into holes made in
PDMS replicates, without any connectors.
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2.3.7 Flow setup and introducing tissues into devices
A customized flow set up was developed for convenient introduction of tumor tissue into
devices (Fig. 2.5A). Important components of the setup were – flow inlet valve, VFin,
packing inlet valve, VPin, flow outlet valve, VFout, and packing outlet valve VPout, flow
inlet syringe SF and packing inlet syringe SP. Initially, all valves and flow channels were
flushed with 20% bleach, phosphate buffer saline, followed by cell culture medium. All
valves were closed. Spheroids were obtained in the packing syringe SP. Valves VPin and
VPout were opened. Spheroids were manually flowed into the device and entered the
culture chamber, where they were retained by filter posts (Fig. 2.5B). After tissues were
located in the chamber, all valves were closed. Valves VFin and VFout were opened and
continuous flow of medium at 3 µl/min was initiated. The entire setup was put together
on a microscope (Fig. 2.5C), which enabled long-term visualization and image
acquisition. Apoptosis in tissues was measured by flowing cell culture medium
containing 0.4 µl/ml Red-DEVD-FMK fluorescent dye (CaspGLOW Red Active
Caspase-3 staining kit; BioVision, Mountain View, CA).

2.3.8 Restriction flow valves
In the very early versions of the device, an external check-valve was attached near the
packing outlet (VPout, Fig. 2.5A) to minimize the flow of fluid and bubbles, if any, into
the cell culture chamber through the filter posts (Walsh et al. 2009). These check-valves
were large and occupied significant real estate on the device and made the devices bulky.
To overcome these problems, on-chip restriction valves were developed and incorporated
into device designs. These restriction valves were placed behind the filter posts (Fig. 2.6)
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to restrict the floe of fluid and air bubbles from behind the valves into the culture
chamber. Four different designs of valves were created and fabricated. The first design
tested (Fig. 2.6A) was very effective and this restriction valve was incorporated in all
devices made thereafter.

2.3.9 Flow setup for stable operation
After tissues were inserted into the culture chambers and flow of medium was initiated,
they were often found to be unstable and flow out into the channels and get washed away.
Increasing the pressure in the channels of the device was used as a method to overcome
this issue. Pressure in the channels of the device was increased by raising outlet valves
above device levels (Fig. 2.7). To measure the appropriate height difference required for
stable operation, spheroids were introduced into chambers, maintaining the outlet valve
high. The height of the outlet valve was decreased gradually and the fate of the spheroid
was observed. Three spheroids were tested in this manner.

2.3.10 Increasing throughput
New device designs were made that contained multiple tissue culture chambers on a
single device. Two different approaches to increasing device throughout were tested. The
chambers in the device were arranged either in parallel (Fig. 2.8A) or in series (Fig.
2.8B). Devices were fabricates using both designs and the spheroid-introduction protocol
was followed to gauge the relative success and ease of operation of each approach.
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2.3.11 Automatic tissue introduction
To improve the efficiency of introducing spheroids into cell culture chambers on the
devices, steps were taken towards the automation of this process. To promote these
devices towards industrial applications, the devices must be able to handle many tissues
and drugs simultaneously. Automated introduction of spheroids into devices will be a
primary requirement. Spheroids were obtained in the packing syringe, SP (Fig. 2.5A). The
syringe was loaded on a syringe pump attached to a wall to keep the syringe needle
pointing vertically downward. The syringe pump was controlled by a computer to vary
flow rates. Tubing was attached to devices by direct insertion into holes. The flow and
location of spheroids through the inlet tubing was observed. Optimal flow rates that
maximize the efficiency of introducing tissues into the chambers were evaluated.

2.3.12 Hanging drop method of spheroid formation
A method for the formation of quick and uniform spheroids from multiple cancer cell
lines was developed. Conventional non-adherent cell culture forms spheroids that have a
large size distribution and take 10-14 days to form. I used the hanging drop method to
successfully form spheroids from three cancer cell lines – human colon carcinoma cells
LS174T, and human breast cancer cells T47D and MDA-MB-231. Cells were trypsinized
and resuspended in culture medium to a desired concentration (Table 2.2). 20 µl droplets
of the suspension were placed on the lid of a 48 well plate. The lid was carefully inverted
and placed on the well plate. Humidity was maintained by adding water to each well of
the well plate. A spheroid formed in each hanging drop at the end of the incubation
period (Table 2.2; Fig. 2.9).
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2.3.13 Generating time-dependent concentration profiles in channels
Time-dependent concentration profiles were created in the channels of the device to
mimic the exponential decay of drugs from plasma. Two computer-operated syringe
pumps were loaded with syringes containing 50 µM and 0 µM fluorescent molecule
fluorescein isothiocyanate (FITC). Flow streams emerging from the two pumps were
mixed using a Y-connector and the mixed stream was introduced into channels of
devices. Algorithms were written to control the flow rates of the pumps in a timedependent manner such that the total flow rate remained fixed but the concentration of
FITC followed a set time-dependent concentration profile. Single exponential (half life =
2 hours) and double exponential (half lives = 4 hours and 8 hours) plasma decay of drugs
were successfully mimicked.

2.4 The effects of motility on bacterial distribution in tumors
2.4.1 Bacterial cultures
Salmonella strains SL1344 (Salmonella Genetic Stock Center, Alberta, Canada) and
VNP20009 (Vion Pharmaceuticals, New Haven, CT), and E.coli strains K12 (MG1655;
ATCC) and DH5α (Invitrogen, Carlsbad, CA) were grown in Luria-Bertani medium (LB)
and on LB-agar plates using standard bacterial culture protocols. SL1344 and K12 are
wild-type strains, VNP20009 is a genetically modified non-virulent strain containing
deletions in the msbB and purI loci, and DH5α is a derivative of K12 that is optimized
for molecular transformations. To enable visualization, all strains were transfected with a
plasmid that constitutively expresses ZsGreen (Clontech, Mountain View, CA). Plasmids
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were transfected by electroporation with a Gene Pulser Xcell (Bio-Rad, Hercules, CA)
system in 1 mm cuvettes using parameters 1.8kV, 25µF and 200Ω.

To quantify bacterial motility, swimming velocities in mammalian cell culture medium
were measured. Liquid cultures of bacteria were grown overnight and resuspended in
Dulbecco’s Modified Eagles Medium (DMEM; Sigma-Aldrich, St. Louis, MO). A 20 µl
droplet of the culture was placed on a glass slide and green fluorescence images were
acquired every 0.53 or 0.62 seconds for 1 minute. To measure velocities, all bacteria in a
frame (approximately 50) were tracked for 5 seconds, X and Y coordinates were noted at
each time frame, and an average velocity was calculated. Bacteria with average velocities
< 0.6 µm/s were designated as non-motile, between 0.6 and 6 µm/s as minimally motile,
and above 15 µm/s as highly motile. Statistical comparison of mean velocities was made
using the Kruskal-Wallis test to account for multimodal distributions.

2.4.2 Mammalian cultures
Human colorectal adenocarcinoma cells (LS174T) obtained from ATCC (Manassas, VA)
were grown in T75 flasks in DMEM with low glucose (1 g/l), supplemented with 10%
fetal bovine serum (FBS; Sigma-Aldrich). Multicellular tumor spheroids were formed by
seeding 2.5 x 104 cells/ml on poly(2-hydroxyethyl methacrylate; Sigma-Aldrich) coated
T25 flasks for 12-14 days. All cultures were maintained under 5% CO2 and 100%
humidity.

Microfluidic devices were used for continuous culture of LS174T tissue and
measurement of the dynamics of bacterial tissue accumulation. We have previously
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measured bacterial motility and accumulation using tumor cylindroids (Kasinskas and
Forbes 2006; Kasinskas and Forbes 2007). The present microfluidic device is an
improvement over cylindroids because continuous medium perfusion prevents
logarithmic growth in the culture medium and enables experiments longer than 20 hours.
In addition, the perfusion of culture medium mimics bacterial delivery and clearance
through the vascular system. Devices were fabricated using standard soft lithography
techniques as described previously (Walsh et al. 2009). Molds for devices were fabricated
by contact soft lithography to produce positive relief SU-8 (MicroChem, Newton, MA)
features over silicon wafers. Replicates were made using Sylgard® 184 Silicone
Elastomer Kit (Dow Corning, Midland, MI). Inlets and outlets were punched with a 1.5
mm biopsy punch and the elastomer chips were bonded to glass slides after oxygen
plasma treatment. Teflon tubing (0.032” ID) was attached to the inlets and outlets of the
devices using barbed luer-lock connectors (Qosina, Edgewood, NY). We have previously
shown that in the device there is no gap between the cells and the glass slide and that this
interface does not affect molecular transport (Walsh et al. 2009).

Spheroids were introduced into 1000µm x 300µm x 150 µm chambers on the devices to
form cuboidal tissue as described previously (Walsh et al. 2009) and were incubated for
24 hours at 37°C in a customized temperature controlled incubator built on a microscope.
Humidity and pH inside devices were maintained by continuous perfusion of HEPES (25
mM) buffered DMEM at 3 µl/min. Ampicillin (100 µg/ml) was maintained in all flow
solutions introduced into the device to maintain plasmids in transformed bacteria.
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2.4.3 Bacterial treatment and apoptosis detection
Bacterial cultures were grown overnight in LB, centrifuged and resuspended in DMEM,
diluted to a concentration of 105 or 107 CFU/ml, and introduced into devices at 3 µl/min.
After 1 hour, devices were flushed with bacteria-free medium. Bacterial colonization was
monitored for 34 hours post-inoculation. Inoculation densities of 105 CFU/ml were used
for all 4 strains and 107 CFU/ml were used for the two E. coli strains. Controls were run
without bacterial inoculation. At least 3 tissues were tested under each condition and
statistical comparisons were made using Student’s t-test. All error bars represent standard
errors of the mean.

Apoptosis in tissues was detected by maintaining 0.4 µl/ml Red-DEVD-FMK fluorescent
dye (CaspGLOW Red Active Caspase-3 staining kit; BioVision, Mountain View, CA) in
all flow solutions. Red-DEVD-FMK is cell permeable, non-toxic, and irreversibly binds
to activated caspase-3, a marker of apoptotic cells. The dye was introduced after 24-hour
incubation of tissues in devices, and 6 hours prior to bacterial inoculation to allow
penetration of the dye into tissue.

2.4.4 Image acquisition and data analysis
All images were acquired using an Olympus (Center Valley, PA) IX71 inverted
epifluorescent microscope equipped with Plan-APO 10x and SLCPlan 40x objectives. To
capture an entire chamber of the microfluidic device (1000 µm x 300 µm), 2 images
(867.15μm x 660.68μm each) obtained at 10x were tiled using a macro in IPLab (BD
Bioscience, Rockville, MD). Transmitted light and green and red fluorescent images of
chambers were captured at 1-hour intervals after bacterial inoculation. For quantification
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of bacterial motility, green fluorescence images of individual bacteria were obtained at
40x. Green and red images were captured using 470/40 nm and 546/10 nm excitation and
525/50 nm and 590 nm long pass emission filters (Chroma, Rockingham, VT),
respectively.

Intensity values from green and red images were used to generate space and time profiles.
A rectangular region of interest (ROI) incorporating each tissue was created at every time
point. For each ROI, a background subtracted average intensity was calculated, and a
linear average intensity profile was generated by averaging pixel intensities along
successive widths of the ROI. Distances were normalized by the length of the ROI, which
changed as the tissue grew. For analysis, the zero time point was set to be immediately
after clearance of bacteria from channels. At 30 hours, the penetration depth of each
bacterial strain was calculated for inoculation densities that resulted in detectable
colonization, as the distance from the flow channel at which bacterial intensity decreased
to 10% of its maximum. In cases where the intensity did not fall to 10%, the penetration
depth was assumed to be greater than the length of the ROI. The entire procedure was
automated using a customized script in MATLAB (The MathWorks Inc, Natick, MA).

Intensity values from green fluorescence images were calibrated to obtain bacterial
densities within spheroids. For each bacterial strain, a suspension in DMEM with a
known density was introduced into a device that did not contain tissue, and images were
acquired before and after introduction of the suspension. A calibration was performed to
relate fluorescence intensity to bacterial concentration. The OD600 to CFU/ml
conversion factor was experimentally determined to be 5x108 by plating cultures of
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known density on LB agar plates and counting colonies. To calculate bacterial density
per tissue mass, the density of tissue was assumed to be 1 g/ml. In cases where bacterial
accumulation was undetectable, the bacterial density was assumed to be at or beneath the
detection limit of the camera. To estimate the relative colonizing ability of each strain, a
normalized dimensionless bacterial concentration was evaluated by dividing the bacterial
density in tissue at 30 hours by the inoculation density.

2.4.5 Mathematical model of bacterial penetration and growth
A mathematical model was used to determine the relative contribution of dispersion and
growth to the amount and location of bacterial accumulation in tissue. The model
balanced accumulation with dispersion and growth:

∂Cb
∂ 2C
= D 2b + µCb
∂t
∂x

(8)

where Cb (cells/µm3) is the average bacterial concentration, D (µm2/s) is the dispersion

€

coefficient, µ (1/s) is the growth rate, and x (µm) is the distance from the edge of tissue.
To account for the one-hour bacterial inoculation, concentration at the front edge of tissue
was set to the inoculation density for the first one hour, and to zero after that. Bacteria
that penetrated tissue in the first hour spread into the tissue and colonized. The model was
solved to obtain spatiotemporal bacterial profiles, Cb(x,t), for 40 hours after inoculation.
Experimental data was fit to the model to determine the values of parameters D and µ for
each strain. The mathematical model of bacterial penetration and growth (Eq. 8) was
based on a similar model developed previously in our laboratory (Kasinskas and Forbes
2006). The model was discretized using finite differences to obtain a set of algebraic
equations and solved using Implicit Euler’s method to 40 hours post inoculation.
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Gradients in bacterial concentration along the width of the chamber were assumed to be
negligible. The initial concentration of bacteria in tissue was zero. An impermeable
boundary was assumed at the rear end of the tissue. The concentration at the front edge
was set to 105 or 107 CFU/ml for t ≤ 1 hr and to zero for t > 1 hr to match experimental
conditions. The size of the tissue (L = 800µm) was assumed to be constant because its
rate of change was considerably slower than the rate of bacterial dispersion and growth.

To determine optimal values of D and µ, unconstrained nonlinear optimizations were run
using the MATLAB function fminsearch to minimize the sum of squared errors between
the simulated and experimental profiles at 30 or 34 hours. Parameters were fit to three
independent experiments for each strain. Averaged optimized parameter values were used
to generate optimum simulated profiles. 105 CFU/ml inoculation experiments were used
for Salmonella strains and 107 CFU/ml experiments for E.coli strains. To demonstrate the
relative contribution of parameters D and µ, 30-hour spatial profiles were generated for
nominal parameters D = 0.1 µm2/s, µ = 0.55, 0.57 and 0.60 hr-1, and for µ = 0.57 hr-1, D =
0.02, 0.07 and 0.17 µm2/s.

2.5 The effects of transport and binding on drug efficacy
2.5.1 Mammalian cell culture
Human colon adenocarcinoma cells LS174T (ATCC, Manassas, VA) were grown in
Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich, St. Louis, MO)
containing 1 g/L glucose and 10% fetal bovine serum (Atlanta Biologicals,
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Lawrenceville, GA), pH 7.4, using standard cell culture protocol. Cells were incubated at
37°C in ambient air with 5% CO2 and 100% relative humidity. Spheroids were made by
plating single cell suspensions, 2.5 x 104 cells/ml, on non-adherent poly(2-hydroxyethyl
methacrylate)-coated T25 flasks.

2.5.2 Perfused tumor tissue culture
Microfluidic devices were used for continuously perfused culture of tumor tissue.
Spheroids were introduced into 1000 µm x 300 µm x 150 µm chambers on the devices to
form cuboidal tissues that were subjected to continuous medium perfusion along one
face. Tissues were incubated for 24 hours at 37°C in a customized heated enclosure on a
microscope before subsequent drug treatment. Humidity and pH was maintained by
flowing 25mM HEPES buffered DMEM at 3 µl/min. Devices were constructed using
standard soft lithography techniques as described previously (Toley et al. 2011; Walsh et
al. 2009). Molds were made by selectively exposing SU-8 (MicroChem, Newton, MA)
coated wafers to UV light through photomasks to produce positive-relief features.
Replicates were made using Sylgard® 184 Silicone Elastomer Kit (Dow Corning,
Midland, MI). A 1.5 mm biopsy punch was used to make holes for connecting inlet and
outlet tubing.

2.5.3 Doxorubicin and Doxil treatment
Tumor tissues incubated in microfluidic devices for 24 hours were treated with 5 µM
doxorubicin (Sigma-Aldrich, St. Louis, MO) for 10.5 hours. In another experiment, the
penetration and retention of doxorubicin was compared with Doxil. 50 µM each of Doxil
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and doxorubicin were introduced in two separate devices for 8 hours. Doxil was obtained
as a kind gift from Dr. T. Emrick (University of Massachusetts Amherst, Amherst, MA).
All drug treatments were followed by clearance of drugs by flushing the devices with
drug-free medium. All experiments were run in multiple replicates (n=3). Two-tail
Student’s t-test was used for statistical comparisons. Errors are reported as standard
errors of the mean.

2.5.4 Image acquisition and analysis
All images were acquired using an Olympus (Center Valley, PA) IX71 inverted
epifluorescent microscope equipped with a Plan-APO 10x objective. Doxorubicin and
Doxil naturally fluorescence red. Transmitted light and red fluorescent images were
acquired every 30 minutes immediately after drugs were introduced into the device. To
capture an entire culture chamber (1000µm x 300 µm), two adjoining images (867.15µm
x 660.68µm each) were obtained and tiled using a macro in IPLab (BD Bioscience,
Rockville, MD). Fluorescent images were acquired using a 560/10 nm excitation and a
590 nm long pass emission filter (Chroma, Rockingham, VT). Intensity values obtained
from fluorescent images were used to generate space and time profiles. Rectangular
regions of interest (ROI) incorporating each tissue were created and backgroundsubtracted linear intensity profiles were generated by averaging intensities along
successive widths of the ROIs. Distances were normalized by the length of the ROIs and
intensity values from tissues were normalized by the maximum background-subtracted
intensity of flow channels. For comparison of overall drug uptake by tissues, average
normalized intensity values over entire ROIs were obtained at all time points.
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2.5.5 Mathematical model for drug diffusion and binding
A mathematical model combining the effects of drug diffusion and binding with those of
PK and PD was developed. The model incorporated four important mechanisms: a)
diffusion into tissue, b) binding, c) systemic clearance, and d) cell killing. It balanced the
concentration of three entities: free drug (A), bound drug (B), and live cell density (l). The
model contained seven critical parameters: diffusivity of drug, D, forward and backward
reaction rate constants for drug binding, kon and koff, maximum concentration of drug
binding sites in tissue, Smax, cell death related parameters, µd,max and Km, and the half-life
of drug clearance, Thalf. Drug binding was assumed to be a reversible reaction with a 1:1
drug:site stoichiometry, A + S "
$# B , where S is the concentration of free drug
binding sites. The binding constant, R, was defined as R = kon/koff. Cell death was
!
assumed to be a function of the effective drug concentration, E = A + B, and had

saturation kinetics with a maximum death rate µd,max and saturation constant Km.
Consequently, the following set of partial differential equations was obtained:

€
€

∂A
∂2A
= D 2 − (k on A.S − k off B)
∂t
∂x

(9)

∂B
= k on A.S − koff B
∂t

(10)

∂l ⎛ − µd . max E ⎞
= ⎜
⎟. l
∂t ⎝ K m + E ⎠

(11)

where x is the distance from the front edge of tissue, in contact with flowing medium.

€

Because the number of drug binding sites was limited, S was calculated as the difference
between the maximum concentration of binding sites and the concentration of occupied
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sites, S = Smax – B. The concentration of A at the front edge (x = 0) was an exponential
decay with half-life Thalf. An impermeable boundary was assumed at the rear end (x = L =
600 µm). Concentrations of A and B were set to zero and the live cell density, l, was set
to 1 at the initial time point. Equations 1-3 were discretized using finite differences into a
set of non-linear algebraic equations and solved for A, B and l in space and time using the
MATLAB (The Mathworks Inc, Natick, MA) function fsolve. To demonstrate the
contribution of clearance, diffusion and binding towards cell death, the model was solved
for a hypothetical drug X, with nominal parameters µd,max = 0.1 hr-1 and Km = 0.01 µM,
using several combinations of parameter values.

2.5.6 Mathematical model for encapsulated drug diffusion and release
The free drug model was extended to determine the effects of liposome encapsulation.
Liposome encapsulation added two important parameters to the model: the rate of
irreversible drug release from liposomes, krel, and diffusivity of liposomes, Dlip, and
modified the half-life, Thalf of the drug. The following equations were obtained:

€

∂LipA
∂ 2 LipA
= Dlip
− k rel LipA
∂t
∂x 2

(12)

∂A
∂2A
= D 2 − (k on A.S − k off B) + k rel LipA
∂t
∂x

(13)

where LipA and A are the concentrations of liposome encapsulated and free drug

€

respectively. After drug was released from liposomes, it underwent binding and caused
cell death similar to free drug (Immordino et al. 2006), as described by equations 10 and
11. Encapsulated drug was assumed to have no cytotoxicity. Liposomes were assumed to
have a partition coefficient, PC, across the medium-tissue interface. The concentration of
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liposome, LipA, at the front edge was an exponential decay with half-life Thalf. A
convective boundary condition with a large mass transfer coefficient, Kl = 1.1x10-3 m/s,
was set for A. An impermeable boundary was assumed at the rear end. The set of four
partial differential equations, 10, 11, 12 and 13, was discretized using finite differences
into a set of nonlinear algebraic equations and solved for LipA, A, B and l, in space and
time using the MATLAB function fsolve. To demonstrate the effects of liposome
encapsulation, this model was solved for a range of parameter values for two hypothetical
drugs: a weak-binding drug D1 (R = 10-8 µM-1), and a strong binding drug D2 (R = 10
µM-1), with D = 5x10-11 m2/s, and a fast release rate, krel = 100 s-1. krel - Thalf maps were
drawn for log(Dlip/D) = 0 and Dlip - Thalf maps were drawn for log krel = 2, as explained
below.

2.5.7 Parameter Optimization
Experimental data from doxorubicin and Doxil treatment were used to evaluate optimal
parameters for each drug. For doxorubicin, the free drug model was solved with a timedependent boundary condition that matched the concentration in the channels of the
device. Parameters µd,max and Km were calculated from data published by (Mantovani
1977), and were set to 0.14 hr-1 and 1.66 µM, respectively. The saturation constant, Km,
was assumed to be five-fold higher for cells in spheroids compared to monolayers
(Erlichman and Vidgen 1984). Experimental data from 5 µM doxorubicin treatment was
used for evaluating doxorubicin parameters. The least square error between experimental
and simulated profiles was minimized using the unconstrained nonlinear optimization
MATLAB function, fminsearch, to obtain optimum values of D, R and Smax. These values
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were used to solve the encapsulated drug model. Data from the Doxil experiments were
fit to this model to obtain values of Dlip, krel, and PC. The ratio of intensities of released
to encapsulated drug, 3.28, obtained experimentally, was incorporated in the latter model
to account for increase in intensities due to drug release.
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Table 2.1 Parameters for mathematical modeling oxygen profiles
Parameter

Value

Diffusivity of oxygen in electrolyte
Diffusivity of oxygen in PDMS
Diffusivity of oxygen in cylindroids

Delectrolyte

2 x 10-9 m2·s-1

DPDMS

1.6 x 10-8 m2·s-1

Dcylindroid

1.82 x 10-9 m2·s-1

max

3.58 x 10-16 mol·cell1 -1
·s

Maximum oxygen consumption rate

R

Oxygen consumption saturation
constant

Km

4.64 x 10-3 mM

Volume of live cell

VL

4.97 x 10-9 cm3

Volume of dead cell

VD

2.49 x 10-9 cm3

Table 2.2 Parameters for Hanging Drop Spheroids
Cell Line

Required Cell Concentration

Incubation Time

LS174T

300 cells/µL

2-3 days

T47D

750 cells/µL

3-4 days

MDA-MB-231

150 cells/µL

5-6 days
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Figure 2.1 Design of the micrometer-scale oxygen delivery device. A. Schematic of the
oxygen delivery device. Oxygen is generated at the anode and diffuses through the
electrolyte and PDMS into the cylindroid. The cylindroid resides in a cell culture
chamber and is positioned over the anode by the positioner. B. The microenvironments
within a cylindroid are heterogeneous. Cells near the periphery are healthy and
proliferating and cells in the interior are dying. C. Oxygen is generated at the anode
through electrolysis by the passage of a DC current. D. The positioner is composed of a
plug attached to a head, which rests on a base. The X and Y location is adjusted by
moving the plug laterally, and the thickness of the cylindroid (Z) is controlled by the four
screws.
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Figure 2.2 Photomasks. Photomasks are made by obtaining negative prints of desired
features. The features are transparent and the mask is opaque.

Figure 2.3 Mold fabrication and device replication. A. Molds are formed by selectively
exposing SU-8 to ultraviolet light through photomasks, followed by developing. B.
Multiple PDMS replicates can be obtained from a mold.
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Figure 2.4 Schematic of punching, bonding and tubing connection. Schematic showing a
PDMS replicate (A), punched holes (B), bonding to a glass slide (C) and attaching tubing
using luer-lock connectors (D).
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Figure 2.5 Schematic showing flow setup for tissue introduction. (A), tissue inserted in a
culture chamber (B), and the device positioned on a microscope for imaging (C).
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Figure 2.6 Restriction flow valves. These on-chip features were introduced behind the
filter posts. Four different designs were created.

Figure 2.7 Flow setup for determining the effect of elevated outlet valves.
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Figure 2.8 Parallel vs. serial designs. A. A 4-chamber parallel design with 1 inlet (point
1) and 5 outlets (points 2-6). B. A 6-chamber serial design with 1 inlet (point 1) and 3
outlets (points 2-4).

Figure 2.9 Hanging-drop spheroids. Single spheroids were formed in 20 µl hanging
drops.

58	
  

CHAPTER 3
RESULTS AND DISCUSSION

3.1 Micrometer-scale oxygen delivery rearranges cells and prevents necrosis in
tumor tissue in vitro
3.1.1 Optimized device design
To achieve the design goal of producing localized oxygen at the center of cylindroids
four features were modified: the distance between the anode and the cylindroid, the
design of the channel, the design of the cell chamber, and the method of cylindroid
insertion. The effects of radial oxygen dispersion, which widened the area of oxygen
delivery, were minimized by reducing the distance between the electrode and the
cylindroid. In the final design, the thickness of the electrolyte channel and the PDMS film
were 5 and 10µm, respectively. At this thickness, an unsupported PDMS layer collapsed
during cylindroid formation. To prevent collapse, square PDMS posts, 10 µm on each
side and located 50 µm from each other, were added to the PDMS layer (Fig. 3.1A inset).
To sustain cylindroid culture for the length of a typical experiment, a chamber was
incorporated into the cell culture area that contained enough medium to maintain constant
nutrient concentrations for 60 hours (Fig. 3.1A). Cylindroid position was controlled with
a polycarbonate micro-positioner (Fig. 2.1D), which contained four adjustment screws to
control cylindroid thickness. The positioner could move freely in the plane of PDMS
surface to control X-Y position. This system was able to position cylindroids accurately
over the anode (Fig. 3.1B). For all experiments, the average distance from the cylindroid
center to anode tip was 16 ± 12% of the cylindroid radius.
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3.1.2 Oxygen generation
The operation of the oxygen-generating electrode was tested by passing a high
electrolysis current (10 µA) for 6 seconds to generate an oxygen bubble. When the
electrolysis current was on, the bubble linearly increased in size (Fig. 3.1C,D). After the
electrolysis current was turned off, the bubble shrunk logarithmically and eventually
disappeared (Fig. 3.1C,D). The generation part of the curve was linear with a slope of
8970 ± 460 µm2·s-1 (Fig. 3.1D inset), confirming that the oxygen generation rate was
constant for a fixed electrolysis current. The shrinkage of the bubble was due to oxygen
dissolving into the electrolyte, and diffusion into the cell culture area through the PDMS
roof of the channel. A 100 times higher electrolysis current was used for this experiment
to force the formation of a bubble. The PDMS support posts, most likely, prevented the
bubble from being centered over the anode. When delivering oxygen to tissue however,
electrolytically generated oxygen remained dissolved and localized over the anode.

3.1.3 Cell growth rate
The maximum rate of cell growth was determined from cell culture experiments. Total
area occupied by plated cells (represented by dotted circles) increased over the 32.5-hour
incubation period (Fig. 3.2A,B). By fitting cell areas to an exponential growth
expression, µ gmax was found to be 0.0275 ± 6.5x10-4 hr-1 (n=4).

3.1.4 Effects of oxygenation on cell death in tissue
Supplying oxygen decreased the extent of death in cylindroid centers. Death was
measured using a fluorescence stain (Eth-D1) specific for dead cells with permeable
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membranes (Fig. 3.3A-F). When control, non-oxygenated cylindroids were incubated for
60 hours, staining was observed primarily in the central region (Fig. 3.3B). In all
observed cylindroids the percentage of dead cells steadily decreased from the center to
the periphery (Fig. 3.3C, n=4). In the central annulus (0-10% of the normalized radius)
approximately 60% of cells were dead, which was significantly greater (P<0.05) than the
approximately 5% dead cells in the outer annulus (90-100% of the normalized radius).

The organization of dead cells was reversed in oxygenated cylindroids (Fig. 3.3E).
Minimal staining was observed in the centers, and rings of dead cells were observed at
the edge of all cylindroids (Fig. 3.3E). In all oxygenated cylindroids, the percentage of
dead cells steadily increased from the center to the periphery (Fig. 3.3F; n=4). In the
central annulus, 3% of cells were dead, which was significantly less (P<0.05) than the
29% dead cells in the outer annulus.

Overall, oxygenation decreased the extent of cell death in cylindroids. The average
percentage of dead cells in oxygenated cylindroids (12 ± 2%) was significantly less than
in control cylindroids (31 ± 3%; P<0.05; Fig. 3.3G). Oxygenation also dramatically
altered where dead cells were located. For all central annuli from 0 to 0.5 of the
normalized radius, there were significantly more dead cells in control than oxygenated
cylindroids (P<0.05; Fig. 3.3H). In peripheral annuli from 0.8 to 1.0 of the normalized
radius, oxygenated cylindroids had significantly more dead cells than control cylindroids
(P<0.05; Fig. 3.3H). For control cylindroids, the percentage of dead cells in the inner
annuli was significantly greater than the outer annuli (P<0.05; Fig. 3.3H). This was
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reversed for oxygenated cylindroids; the percentage of dead cells in the outer annuli was
significantly greater than the inner annuli (P<0.05; Fig. 3.3H).

3.1.5 Rearrangement of cells
Using the same fluorescence stain (Eth-D1), the rearrangement of individual dead cells
was tracked during oxygenation. During the period of observation (2.5 hr to 18.5 hr),
several dead cells were pushed toward the outer edge (Fig. 3.4A,B). The only observed
motion of cells was away from the cylindroid center. Many dead cells remained
stationary, and no motion was seen toward the center. Relative to their starting position,
the average rearranged cell changed position by 6% over 16hrs (P<0.01; Fig. 3.4C).
These values were normalized by the growing outer edge of the cylindroid to eliminate
the effects of cylindroid growth. The average velocity of rearranged dead cells was 1.8 ±
0.4 µm/hr, which was significantly greater than zero (P<0.01). Because these cells were
dead and could not actively migrate, it is possible that their observed motion was caused
by chemotaxis of neighboring live cells (Fig. 3.4D).

3.1.6 Steady-state oxygen concentration profiles
Oxygen profiles for a 500µm diameter cylindroid were calculated using a steady state
mathematical model of diffusion and consumption (Eq. 1; Fig. 3.5A,B). The model
accounted for oxygen supplied by the anode and the cell culture medium at the outer edge
(Fig. 3.5A). Radial diffusion in the electrolyte and PDMS layers was minimal (Fig. 3.5A)
and the oxygen supply was tightly positioned at the cylindroid center (Fig. 3.5B). As
desired, oxygen gradients decreased away from the anode at the cylindroid center. In the
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absence of electrolysis current, the cylindroid core was hypoxic due to consumption of
oxygen by the cells (Fig. 3.5B). When oxygen was supplied using a 0.1 µA electrolysis
current, the core became more oxygenated (Fig. 3.5A,B). The outer edges of both control
and oxygenated cylindroids contained similar levels of oxygen (Fig. 3.5B). Based on this
model, the oxygen microenvironments in control and oxygenated cylindroids were
considerably different at the center but almost identical at the outer edge.

3.1.7 Dependence of cell growth and death on local oxygenation
A dynamic mathematical model was used to determine how cylindroid growth and death
responded to oxygen gradients (Eq. 2-7). Three parameters (Kg,ox, Kd,ox , the sensitivities
of cell growth and death to oxygen, and µd,max, the maximum rate of cell death) were
calculated (Table 3.1) by fitting simulated viability profiles (Fig. 3.5D,E) to measured
viability profiles (Fig. 3.3C,F). The simulated viability profiles had similar shapes to the
experimental profiles: death was high in the centers of control cylindroids (Figs. 3.3C &
3.5D) and low in the centers of oxygenated cylindroids (Figs. 3.3F & 3.5E). Similarly,
death was low at the edge of control cylindroids and shifted towards the edge for
oxygenated cylindroids.

The maximum death rate, µd,max, was found to be equal to the measured maximum growth
rate, µg,max (0.0275 hr-1), indicating that cell death by oxygen deprivation is a gradual
process operating over similar time scales (hours) as growth (Table 3.l). The estimated
values of oxygen sensitivity parameters Kg,ox and Kd,ox, indicate how growth and death
rates (µg and µd) vary with oxygen concentration within tissue (Fig. 3.5C). The rate of
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cell growth, µg, is uniform at its highest value except at very low oxygen concentrations.
The rate of cell death, µd, has a stronger dependence on oxygen concentration and
decreases gradually as the concentration of oxygen increases.

3.1.8 Discussion
The reduction of death in oxygenated cylindroids (Fig. 3.3) shows that oxygen acts as the
primary factor controlling cell viability in tumor tissue. In control cylindroids
considerable centralized necrosis was observed, a phenomenon that is well known to
occur in both cylindroids (Kim and Forbes 2007; Kim and Forbes 2008) and spheroids
(Sutherland 1986; Sutherland 1988). When oxygen was supplied to the center of
cylindroids, cell death was almost entirely prevented (Fig. 3.3). This response could have
been mediated by changes in intracellular pH and metabolism, for example. However,
because oxygen supply was the only difference, these results suggest that oxygen controls
cell viability, even in the presence of other metabolic gradients.

Oxygen affected cell viability by both decreasing death and increasing growth (Fig. 3.5).
The mathematical model of cylindroid growth decoupled these effects by generating
independent estimates of cellular growth and death rates as functions of oxygen
concentration (Fig. 3.5C). The saturation constants Kg,ox and Kd,ox (Eq. 7) represent the
sensitivities of growth and death to oxygen availability. The lower value of Kg,ox
compared to Kd,ox indicates that growth is less sensitive to oxygen than death. Oxygen, or
the lack of it, affects cell death across the entire range of oxygen concentrations in
cylindroids, but growth is uniform over most of this range (Fig. 3.5C). As the oxygen
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concentration decreases, the death rate slowly increases but the rate of growth remains
high until the oxygen concentration becomes very low. This interplay is important
because it suggests that in oxygen-limited tumor regions, cell death will occur before
growth ceases. The presence of growth at low oxygen concentrations explains how small
populations of proliferating cancer cells can persist in hypoxic environments and
eventually become resistant to hypoxia-induced apoptosis (Hockel et al. 1999; Yao et al.
2005). This selection would occur despite the fact that most cells in hypoxic regions are
committed to death.

In addition to preventing death, supplying oxygen altered the distribution of dead cells in
cylindroids (Figs. 3.3,3.4). Control cylindroids had dead cores and viable peripheries,
whereas oxygenated cylindroids had viable cores and rings of dead cells at the peripheral
edges (Fig. 3.3). The observed movement of dead cells (Fig. 3.4) indicates that this
reorganization in response to oxygenation was caused by individual cell migration. It is
unlikely that the environment at the edge caused the death seen in oxygenated cylindroids
(Fig. 3.3E), because death was not observed at the edge of controls cylindroids (Fig.
3.3B). The outside edges of all cylindroids were well supplied with oxygen and nutrients.
The steady-state oxygen diffusion model (Eq. 1) predicted that the oxygen concentration
in the outer region is similar in control and oxygenated cylindroids (Fig. 3.5B). In
addition, the concentrations of other nutrients near the edges would not be affected by
supplying oxygen to the centers.
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Two different mechanisms could have contributed to the observed cellular
rearrangement: passive displacement caused by cell viability gradients and active cell
chemotaxis. Passive cell growth is a convective velocity caused by the expansion of
growing cells and contraction of dying cells (Venkatasubramanian et al. 2006). If passive
viability gradients were the predominant mechanism, dead cells would have been pushed
from the center as the volume of proliferating cells expanded due to the supply of
oxygen. This relocation would have resulted in the observation of cell death along a band
between the center and the edge where the oxygen concentration was lowest (similar to
the maximum in Fig. 3.5E). Death would be minimal at the center and the edge where
oxygen was readily available. If active chemotaxis were the predominant mechanism,
viable cells at the periphery would have sensed the oxygen gradient and moved toward
the cylindroid center (solid arrows, Fig. 3.4D). This internalization would have displaced
dead cells, which were unable to migrate, toward the outside edge (dashed arrows, Fig.
3.4D), creating the observed ring of dead cells. Active cell migration in spheroids has
been observed previously, and the time-scale for rearrangement was measured to be
approximately 48-72 hours (Dorie et al. 1982), similar to the 60 hour time-scale
investigated here. The observation that dead cells were mostly located at the outer edge
(Fig. 3.3) rather than in an intermediary band (Fig. 3.5E), suggests that active chemotaxis
was the principal cause of cellular rearrangement.

The redistribution of cell populations in response to oxygenation suggests that changes in
oxygen gradients within tumors may induce metastasis by rearranging cell populations.
Tumors have heterogeneous and dynamic oxygen microenvironments; the chaotic
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vascular structure typical in tumors (Vaupel et al. 1989) creates vessels with both high
and low oxygen concentrations. Angiogenesis, vascular stasis and fluctuations in red
blood cell flux, constantly change the location of oxygen sources and the oxygenation
state of cell populations (Dewhirst 2007; Kimura et al. 1996). The observation that dead
cells localize to the peripheries of oxygenated cylindroids suggests that changing oxygen
microenvironments promote continual tissue remodeling. Viable cells that chemotax
toward well-oxygenated vessels would push dying cells toward less-oxygenated vessels.
Proximity to vessels would promote intravasation (Wyckoff et al. 2000) and cell
shedding (Butler and Gullino 1975) into the bloodstream, two steps in the formation of
metastasis. Consequently, as the proportion of defunct or oxygen lean vessels increases,
the likelihood of metastasis would increase. This mechanism may explain the previously
observed correlation between hypoxia and metastatic disease (Brizel et al. 1996).

3.2 The effects of surface charge of gold nanoparticles on doxorubicin delivery in
tumor tissue
3.2.1 Dox-AuNP uptake in monolayers
Dox-AuNP uptake was dependent on cell viability (Fig. 3.6 A-C). Following growth in
medium or saline, cells were either viable or dead as confirmed by staining with Eth-D1
(Fig. 3.6C, left). Both positive and negative particles were taken up by viable cells, but
uptake was significantly greater in necrotic cells (P<0.05; Fig. 3.6C, right). Non-viable
cells have greater uptake because they have lost membrane integrity.
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3.2.2 Dox-AuNP uptake in cylindroids
Similar to FITC-AuNP (previous work), a positive surface charge dramatically enhanced
uptake of DOX-AuNP into proliferating peripheral cells compared to negative particles
and free drug (Figure 3.7). In cylindroids, positive particles delivered more doxorubicin
than negative particles (Figure 3.7A-B). By location, positive particles delivered
significantly more doxorubicin to viable cells in the cylindroid periphery, compared to
negative particles and free drug which were preferentially taken up by dead cells at the
cylindroid center (P<0.05; Figure 3.7D). This charge dependent localization was
consistent over the 46 hours of the experiment (P<0.05; Figure 3.7E), during which the
concentration of particles and free drug increased within cylindroids (Figure 3.7A-C,
radial profiles).

3.3 Fabrication, operation, and optimization of microfluidic devices for continuous
tumor tissue culture
3.3.1 Optimum method for creating holes
Direct drilling or punching did not produce smooth and clean holes to enable connecting
tubing. ‘Punch-drilling’ created holes of acceptable quality. However, the piece of tubing
used for drilling had to be regularly sanded to maintain sharpness. The most successful
way of creating holes was by using biopsy punches. The razor sharp circular blade of the
biopsy punches created holes with smooth walls and allowed smooth passage of tissue
through them.
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3.3.2 Optimum method for bonding
The two methods used for bonding – ratio mismatch bonding and oxygen plasma
treatment – had different benefits and shortcomings. The success of oxygen plasma
treatment was not 100% and remains at around 70% to date, which means that around 3
out of every 10 devices made by this technique leaked. When bonding was successful,
tissues remained stable in the devices for 2-3 days. Bonding to glass allowed imaging
through glass slides optimized for light transmittance. The success of the ratio mismatch
bonding technique was very close to 100% and the bonds obtained were very strong. One
disadvantage of this technique was that imaging was done through the bottom surface of
plastic petri dishes and thin layers of PDMS. These materials are not optimized for
imaging and this can potentially affect image quality. However, a major limitation of the
ratio mismatch bonding was that long-term operation of the device was hindered by
appearance of bubbles in the system. These bubbles were most likely a result of dissolved
air in the thin layer of PDMS getting displaced by water from the flow channels.
Consequently, plasma treatment to glass slides is the optimum technique for bonding.

3.3.3 Optimum method for connecting tubing
Inserting tubing into PDMS, while it cured, did not work successfully and devices leaked
often. Inserting blunt needles was promising but needles were very tall and devices did
not fit on the microscope for imaging. The luer-lock interface method was very
successful because the barbed connector provided very good sealing and avoided leaking.
Luer-lock connectors were used for a significant amount of the work described in this
dissertation. Nearer to the end of this work, I discovered that if the quality of the holes
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made in PDMS replicates was very good, and the holes did not have any rough walls and
were clear of debris, then PTFE tubing could be inserted directly into the holes without
any connectors. The sealing obtained was very good and devices were leak-free. The
device real estate occupied by tubing inserted this way is minimal and enables scale-up of
these devices. This is the optimal way of connecting tubing to devices.

3.3.4 Formation of cuboidal tumor tissue
After construction of devices, the flow setup and method for introducing spheroids
(section 2.3.7) was followed correctly, and a cuboidal tumor tissue constrained in the
culture chamber of the device was obtained (Fig. 3.8A). The dimensions of the culture
chamber were 1mm x 0.3mm x 0.15mm. Apoptosis detection by a fluorescent marker
showed that the regions of the tissue in proximity of flow channels had minimal apoptosis
and the regions farther away from channels had the maximum apoptosis (Fig. 3.8B). This
trend continued for 3 days.

3.3.5 Optimal setup for stable operation
Increasing outlet valve height relative to the device increased pressure in the channels of
devices and prevented tissues from flowing into channels. For height differences less than
6 inches, spheroids had a tendency to slip out of chambers (Fig. 3.9). For height
differences over 11 inches, the spheroids were retained in the chambers (Fig. 3.9). The
minimum height differential between the device and the outlet valve was determined to
be 11 inches. All device experiments conducted after this point maintained outlets 11
inches above the devices.
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3.3.6 Increasing throughput
The two approaches – serial vs. parallel (Fig. 2.8) – both had certain advantages and
disadvantages. The advantage of parallel operation was that all chambers on the device,
C1 – C4 (Fig. 2.8A), received fresh medium split in equal flows from the primary inlet.
The disadvantages were that for housing 4 tumor tissues, 6 total inlets and outlets were
required (Fig. 2.8A). As the device is scaled up further, the number of outlets increases,
making operation tedious. Further, it was difficult to introduce tissues into each chamber
individually. After a tissue was flowed into one chamber, it often got pushed back out of
the chamber in the process of flowing tissue into another chamber.

Serial operation eliminated some of the disadvantages of parallel operation. For one
design containing 6 culture chambers, C1 – C6 (Fig. 2.8B), only 4 total connections for
inlets and outlets were required. In theory, many more chambers can be added to the
main central channel while maintaining the same number of connections. Most
importantly, this design was significantly easier to introduce tissues compared to the
parallel device (Fig. 2.8A). Fig. 3.10A shows 4 tumor tissues introduced into chambers
of a serial device. At least 3 tissues could consistently be packed in this design and could
be used for biological experiments in statistically significant replicates. The only
disadvantage of serial operation was that all tissues did not receive fresh medium. This
shortcoming could be overcome by maintaining a flow rate of medium high enough that
there was no nutrient depletion due to consumption. A flow rate of 3 µl/min was used for
culturing many tissues in the serial device and seemed to sustain the growth of all tissue
for more than 3 days. Serial operation was determined to be the optimum method.
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Devices were designed to further increase throughput. Serial mode of operation was used
for making designs for simultaneous treatment of tumor tissues to 8 different treatments.
Each treatment was introduced in a channel that could hold 6 tumor tissues. Designs were
drawn and optimized to incorporate 48 tissue chambers (8 treatments across 6 tissues)
within the bounds of a 75mm x 50mm glass slide (Fig. 3.10B).

3.3.7 Automatic tissue introduction
A flow rate of 20 µl/min was found to be optimum for automated introduction of tissues
into microfluidic devices. Using this flow rate ensured proper ejection of all spheroids out
of the syringe needle. The efficiency of ejection was much higher than manually pushing
spheroids out. Passage of spheroids through the tubing at this flow rate was very slow.
Often, manual intervention was used to accelerate the flow through the tubing. At 20
µl/min, the passage of tissues through the channels into the chambers was very smooth.
Spheroid entered serially arranged chambers sequentially. Fig. 3.11 shows successful
tissue introduction into all 6 chambers of a serial device.

3.3.8 Hanging drop method of spheroid formation
Hanging drop spheroids were successfully generated from three cancer cell lines (Fig.
3.12). The time period required for formation of spheroids by this method was in between
2 to 6 days. Compared to non-adherent cultures, this is a quicker method of forming
spheroids.
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3.3.9 Time-dependent concentration profiles
Single exponential (Fig. 3.13A) and double exponential (Fig. 3.13B) decays were
modeled using automated syringe pumps. Experimental data fit the modeled
concentration profiles well. These results show that these devices can be used to
accurately mimic the systemic clearance of drugs.

3.4 Motility is critical for effective distribution and accumulation of bacteria in
tumor tissue
3.4.1 Quantification of bacterial motility
Bacterial motility was quantified by time-lapse imaging of cells suspended in DMEM
(Fig. 3.14A). The two Salmonella strains, SL1344 and VNP20009, were more motile
(P<10-4) than the two E. coli strains, K12 and DH5α (Fig. 3.14A,B). The average
velocity of Salmonella was 14.5 ± 0.9 times that of E.coli. Among the four bacterial
strains tested, average velocity decreased in the order: SL1344, VNP20009, K12 and
DH5α (Fig. 3.14B). The distribution of velocities also differed between the strains.
SL1344 and VNP20009 had bimodal distributions with a fraction of their population
being highly motile (Fig. 3.14C). The maximum velocity of SL1344, 26.5 µm/s, was
higher than that of VNP20009, 23.6 µm/s (Fig. 3.14C). The fraction of SL1344
population that was highly motile was greater (P<0.05) than VNP20009 and the fraction
that was minimally motile was lower (P<0.05) than VNP20009 (Fig. 3.14D). The entire
population (100%) of the two E. coli strains K12 and DH5α was minimally motile (Fig.
3.14D) and this fraction was greater (P<0.05) than the fractions of minimally motile
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Salmonella strains (Fig. 3.14D). The distribution of velocities for E.coli strains was
unimodal (Fig. 3.14E) and the average velocity of K12 was higher (P<10-3) than that of
DH5α. The fraction of K12 population that was minimally motile was higher (P<0.01)
than that of DH5α (Fig. 3.14F). There was no difference in size between individual
bacterial of the four strains.

3.4.2 Accumulation of different bacterial strains in tissue
The accumulation of bacterial strains in tissue was measured in an in vitro model that
consisted of rectangular human colon carcinoma tissue subjected to continuous medium
perfusion through a microfluidic channel along one of the edges (Fig. 3.15A). This model
was specifically designed to mimic the delivery and systemic clearance of bacteria. 105 or
107 CFU/ml suspensions of bacteria, engineered to express ZsGreen for visualization,
were introduced into flow channels and flushed after one hour. Time-lapse microscopy
was used to monitor their tissue accumulation over 34 hours after flushing. All results
were seen in multiple replicates (n ≥ 3). At 105 CFU/ml inoculation, the accumulation of
SL1344 in tissue increased after flushing, and was negligible in flow channels (Fig.
3.15B). After 10 hours, accumulation of SL1344 in tissue was significantly higher
(P<0.05) than in channels (Fig. 3.15B), confirming that systemic clearance of bacteria
was successfully mimicked. The total amount of bacterial accumulation in tissue varied
considerably between the four strains (Fig. 3.15A). When inoculated at 105 CFU/ml, only
the two Salmonella strains SL1344 and VNP20009 had detectable colonization in tissues
and there was no detectable colonization of the two E.coli strains K12 and DH5α (Fig.
3.15A). Amongst the Salmonella strains, SL1344 exhibited higher accumulation in tissue
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compared to VNP20009, over the 30-hour observation period (Fig. 3.15A,C). At 30
hours, the accumulation of SL1344 was 15±3.6 times greater (P<0.05) than VNP20009
and at least 1000 times greater (P<0.05) than both E.coli strains (Fig. 3.15E). The
accumulation of VNP20009 was at least 80 times greater (P<0.05) than both E.coli
strains (Fig. 3.15E). The tissue accumulation of the four strains strongly correlated with
motility (R2 = 99.27%; Fig. 3.15E).

A higher inoculation density (107 CFU/ml) was used to observe the accumulation of the
two E. coli strains (Fig. 3.15D,F), because they did not accumulate at detectable levels at
the lower inoculation density (Fig. 3.15B,C). Both strains showed detectable levels of
accumulation at the higher inoculation density, and K12 accumulated more than DH5α
(Fig. 3.15B,D). At 30 hours, the accumulation of the more motile K12 strain was
significantly higher (P<10-3) than the less motile DH5α strain (Fig. 3.15F), in accordance
with the motility-accumulation correlation at low inoculation densities (Fig. 3.15E).

3.4.3 Spatial distribution of bacterial accumulation
The four bacterial strains had different spatial distributions within tissue (Fig. 3.16A,B).
Most notably, strains differed in their ability to penetrate tissue and colonize regions
distant from the flow channels. The proximal region of tissue between normalized
distances of 0.1 and 0.2 was designated as ‘zone-1’ and the distal region between 0.5 and
0.6 as ‘zone-2’. Colonization initiated in zone-1 and progressed to zone-2 (Fig. 3.16C,D).
SL1344 penetrated deeper into tissues compared to VNP20009 when inoculated at 105
CFU/ml (Fig. 3.16A,C). The two E.coli strains did not colonize at this seeding density. At
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30 hours, the zone-1 and zone-2 accumulation of SL1344 was higher (P<0.05) than other
strains and the accumulation of VNP20009 was higher (P<0.05) than the E.coli strains
(Fig. 3.16E). The accumulation of SL1344 in zone-2 was not significantly less than in
zone-1 (Fig. 3.16E). The zone-2 accumulation of VNP20009 was less (P<0.05) than
zone-1 (Fig. 3.16E). The two E.coli strains K12 and DH5α exhibited different spatial
distributions when inoculated at 107 CFU/ml (Fig. 3.16B,D). K12 penetrated deeper than
DH5α (Fig. 3.16B,D). At 34 hours, the zone-1 and zone-2 accumulation of K12 was
higher (P<0.05) than that of DH5α (Fig. 3.16F). The zone-2 accumulation of both these
strains was less (P<0.05) than zone-1 (Fig. 3.16F). The penetration depth, defined as the
distance where the density was 10% of its maximum, of SL1344 was greater (P<0.05)
than all other strains (Fig. 3.16G). The penetration depths of VNP20009 and K12 were
greater (P<0.05) than DH5α (Fig. 3.16G).

3.4.4 Mathematical model for dispersion and growth of bacteria
A mathematical model was used to determine the relative contribution of dispersion and
growth to the amount and location of bacterial accumulation in tissue. Experimental data
was fit to the model to determine the values of parameters D and µ for each strain (Fig.
3.17A,B,C). The dispersion coefficient, D, was greater (P<0.05) for SL1344 than all
other strains, and was lower (P<0.05; Fig. 3.17B) for DH5α than all other strains. The
growth rate, µ, of SL1344 was the highest (P<0.05), VNP20009 was greater (P<0.05)
than the E.coli strains, and K12 was greater (P<0.05) than DH5α (Fig. 3.17C).
Experimentally obtained penetration depths for the four strains strongly correlated with
dispersion coefficients (R2 = 94.69%; Fig. 3.17D). Similarly, the normalized bacterial
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accumulation at 30 hours had a strong correlation with growth rate (R2 = 99.90%; Fig.
3.17E). Average velocity in aqueous medium correlated with the dispersion coefficient in
tissue (R2 = 70.70%; Fig. 3.17F). To demonstrate the relative contribution of parameters
D and µ, 30-hour spatial profiles were generated for nominal parameters values, which
were selected to generate profiles of similar magnitude to SL1344 experimental profiles.
Based on these profiles, dispersion coefficient, D, had a strong effect on how deep
bacteria penetrated into tissues, and growth rate, µ, had a strong effect on the maximum
concentration of colonization (Fig. 3.17G,H). With increasing D, bacteria penetrated
deeper (location of peaks; Fig.3.17G) and did not affect maximum concentration
(constant height of peaks; Fig. 3.17G). With increasing µ, the maximum concentration of
colonized bacteria increased and did not affect location (Fig. 3.17H).

3.4.5 Apoptosis induction by bacteria
Apoptosis in tissue was detected by maintaining a red fluorescent dye that irreversibly
binds to activated caspase-3, a marker of apoptotic cells, in all flow solutions. Bacterial
accumulation caused apoptosis in the tumor tissue (Fig. 3.18). The extent of apoptosis in
SL1344-treated tissue increased with increasing bacterial accumulation over the 30-hour
observation period and decreased with time for control tissues (Fig. 3.18A,B). Overall
bacterial uptake in tissues correlated strongly (R2 = 98.60%) with the increase in
apoptosis (Fig. 3.18B inset) over time. The increase in apoptosis in tissues varied with
distance from the channel and was greater where there was more bacterial accumulation
(Fig. 3.18C). At 30 hours, the spatial profile of apoptosis increase correlated strongly
with the profile of bacterial accumulation (R2 = 92.90%; Fig. 3.18C inset). For controls,
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apoptosis decreased over entire tissues because of the favorable nutrient environments
caused by continuous perfusion, except in the far distal regions (normalized distances >
0.8), where apoptosis increased marginally because of nutrient deprivation (Fig. 3.18C).
Apoptosis in zone-1 of SL1344-treated tissues at 30 hours was more (P<0.05) than in
zone-2 (Fig. 3.18D). Overall, apoptosis in tissues increased only when and where bacteria
colonized. At 105 CFU/ml inoculation, only the two Salmonella strains SL1344 and
VNP20009 colonized tissues and increased apoptosis higher (P<0.01) than controls (Fig.
3.18E). For the two E.coli strains that did not colonize, apoptosis decreased similar to
controls, and was less (P<0.01) than apoptosis caused by the Salmonella strains (Fig.
3.18E).

3.4.6 Discussion
The in vitro model used for these experiments mimics tumor regions adjacent to blood
vessels. The delivery of bacteria was mimicked by flowing bacterial suspensions through
the microfluidic channel and systemic clearance was mimicked by flushing with bacteriafree medium after one hour of treatment. Based on this arrangement, bacterial
accumulation in the tissue model relates to the tumor colonizing ability of the bacterial
strain, and colonization distant from flow channels relates to the ability of the strain to
penetrate and distribute within tumors.

The higher accumulation of Salmonella compared to E.coli in tissue (Fig. 3.15B)
suggests that Salmonella have better tumor colonizing and anticancer therapeutic
abilities. A 15-fold higher accumulation of SL1344 compared to VNP20009 (Fig.
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3.15C,E) shows that there is significant variability in tissue colonization between strains
of the same species. Less accumulation of VNP20009 may be attributed to the loss of
virulence caused by deletion of msbB and purI loci (Clairmont et al. 2000b). At the lower
inoculation density (105 CFU/ml), only Salmonella accumulated in tissue and the
accumulation of E.coli was undetectable (Fig. 3.16B,C). A 100-fold higher inoculation
density was necessary to observe accumulation of E.coli (Fig. 3.15B). This suggests that
the minimum effective dosage for E.coli-based anticancer therapies would be
significantly higher than Salmonella. High bacterial doses can increase systemic toxicity
and could render E.coli-based therapies ineffective. Minimal accumulation of DH5α,
even at the high inoculation density (Fig. 3.15B,D), further suggests that DH5α has
limited therapeutic ability.

Apoptosis measurements (Fig. 3.18) show that bacteria have a natural therapeutic ability
against tumors. There was no noticeable time lag between bacterial tissue accumulation
and increase in apoptosis (Fig. 3.18A,B,C), indicating that the time scale of apoptosis
induction was short. Because these experiments were performed in vitro in the absence of
an active immune system, apoptosis was not caused by immune sensitization (Forbes
2010). Salmonella that invade mammalian cells are not intrinsically toxic to cancer cells
at low densities (Avogadri et al. 2005). These results suggest that induced apoptosis may
be a result of nutrient deprivation caused by bacterial colonization (Low et al. 1999;
Theys et al. 2006; Weibel et al. 2008). At high bacterial densities, however, invasive
Salmonella may have a deleterious effect on cancer cells, which could be another
mechanism of apoptosis induction.
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Comparison of the penetration of Salmonella and E.coli (Fig. 3.16A) shows that motility
is essential for effective distribution in tumors. Deep penetration of therapeutic agents is
important to overcome the limitations of passive molecules, which cannot treat tumor
regions far from vasculature. Highly motile strains are necessary for the treatment of
advanced primary tumor masses, which are sparsely vascularized, because colonization at
large distances from blood vessels is necessary for eradication. Less motile strains will
colonize only in the vicinity of blood vessels and their therapeutic ability will be limited
to smaller, early stage tumor masses. Effective dispersion and penetration into tumors can
be obtained by using faster bacterial populations, based on the positive correlation
between velocity and dispersion (Fig. 3.17F). If all but highly motile (>15 µm/s) bacteria
were eliminated from the population of VNP20009 used for these experiments, for
example, the average velocity of the population would increase from 6.4 µm/s to 20.5
µm/s. For this hypothetical strain, the tissue dispersion coefficient would increase from
0.114 µm2/s to 0.674 µm2/s (Fig. 3.17F), and the model predicts that these bacteria would
penetrate deeper into tissue (Fig. 3.19A). Bacterial accumulation correlated strongly with
apoptosis (Fig. 3.18C inset). Based on this correlation, deeper penetration of a highly
motile population would cause apoptosis in tumor regions farther than 800 µm from
vasculature (Fig. 3.19B). Without removing the less motile bacteria, the population
would be ineffective at causing apoptosis in regions farther than 400 µm (Fig. 3.19B).
VNP20009 has previously been tested in clinical trials but did not successfully reduce
tumor burden (Toso et al. 2002). Based on these results, elimination of the less motile
fraction, or selecting for the highly motile fraction of a VNP20009 population, would
increase tumor penetration and improve clinical efficacy.
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Bacterial accumulation in tumors is a result of the competing interactions of dispersion
and growth within tissue. Dispersion increases the distance of bacteria from blood
vessels. Growth increases bacterial concentration at the current location resulting in
higher colonization densities. Based on a mathematical model of the relative contribution
of these two phenomena (Eq. 8), higher growth rates can increase colonization densities
but cannot lead to enhanced penetration and colonization in regions of tumors distant
from vasculature (Fig. 3.17G,H). For deep penetration, high bacterial dispersion
coefficients are necessary (Fig. 3.17G,H), which can be obtained by using populations
with higher swimming velocities (Fig. 3.17F and 3.19A). Preferential bacterial growth
within tumor microenvironments is therefore not sufficient to eradicate tumors; a
combination of preferential growth and motility is necessary. Because Salmonella strains
are significantly more motile than E.coli, the two species may adopt fundamentally
different mechanisms for colonizing tumors. More motile Salmonella may actively
penetrate into tumors and subsequently colonize in favorable environments (Fig. 3.19C).
Less motile E.coli, having less ability for active penetration, may colonize near vessels
(Fig. 3.19D). As they grow and divide, their density increases, and individual bacteria
from these colonies slowly move down the concentration gradient away from vessels
(Fig. 3.19D). This mechanism is supported by previous evidence of E.coli penetrating
into narrow constrictions, independent of motility, by means of growth and division alone
(Mannik et al. 2009). Localized accumulation of less motile strains by this mechanism,
however, will be limited by nutrient availability. Motility may therefore increase the
uptake of bacteria in tumor tissues by providing them access to new regions and sources
of nutrients (Fig. 3.19A,C).
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3.5 Transport-binding coupled pharmacokinetic/pharmacodynamic model predicts
important mechanisms of doxorubicin and Doxil therapeutic effect
3.5.1 Effects of drug diffusion and binding
To demonstrate the relative contribution of drug clearance, diffusion, and binding,
treatment with a hypothetical drug X for 20 hours was simulated under four different
conditions. Case1: In the absence of transport limitations, clearance, and binding, drug X
decreased the 20-hour live cell density (l20) to 13% (Fig. 3.20A). An l20 dose response
curve was obtained for this drug (inset; Fig. 3.20A). Case2: A nominal clearance rate was
introduced, Thalf = 0.5 hours. In 7 hours, the live cell density decreased to 58% and
remained constant after that (Fig. 3.20B) Case3: Transport limitations were introduced by
setting diffusivity, D = 2x10-11 m2/s, maintaining the same clearance rate. l20 decreased to
27% (Fig. 3.20C). Case4: A moderate binding constant, R = 0.1 µM-1, was introduced.
This decreased l20 to 16% (Fig. 3.20D). When plotted as a function of diffusivity, l20
displayed a minimum (15%) at around 10-11 m2/s (Fig. 3.20E). l20 was 58% for very high
diffusivities and 100% for very low diffusivities (Fig. 3.20E). The effect of binding on
drug efficacy was different at different diffusivities. For high diffusivities, D = 10-9 and
10-10 m2/s, the response-binding curves had negative slopes (dotted lines; Fig. 3.20F). At
D = 10-11 m2/s, the response-binding curve was nearly flat (gray line, Fig. 3.20F). For
low diffusivities, D = 10-12 and 10-13 m2/s, the response-binding curves had positive
slopes (Fig. 3.20F, dark lines).
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3.5.2 Effects of liposome encapsulation
Liposome encapsulation increases the half-life of clearance, decreases diffusivity, and
introduces a rate of drug release. The effects of liposome encapsulation on cell death
depended on the binding characteristics of the encapsulated drug. Increasing the half-life
of the strong binding drug D2 beyond 2 hours did not decrease l20 significantly (Fig.
3.21A). Increasing the half-life of the weak-binding drug to 6 hours and beyond
continued to decrease l20 (Fig. 3.21A). When half-life was increased from 0.5 to 6 hours,
drug D1 decreased l20 by ΔD1 = 48%, and drug D2 by ΔD2 = 13% (Fig. 3.21A). Drug
release rate, krel, had a strong effect on both drugs D1 and D2 (Fig. 3.21B). For both
drugs, l20 increased with decreasing release rates (Fig. 3.21B). At very low release rates,
l20 was 100% and at very high release rates, the free drug limit was reached (Fig. 3.21B).
The effects of decreased diffusivity as a result of encapsulation differed significantly
between drugs D1 and D2 (Fig. 3.21C). For D1, l20 increased rapidly with decreasing
liposome diffusivity. For D2, l20 decreased only when the diffusivity decreased below 6
orders of magnitude (Fig. 3.21C). Encapsulation within liposomes that decrease
diffusivities up to three orders of magnitude had no effect on drug D2 and a strong effect
on drug D1 (inset; Fig. 3.21C). Liposome encapsulation of drugs had competing effects
on cell death – limited release and reduced diffusivity decreased efficacy, and enhanced
half-life incresed efficacy. To elucidate the effects of encapsulation, krel - Thalf and Dlip Thalf maps were drawn for each drug (Fig. 3.21D-G). Each curve on the map represents a
single clearance rate. Moving from the top to the bottom on each map increases Thalf and
decreases l20. Moving from right to left on the maps decreases krel or Dlip and increases
l20.
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3.5.3 Doxorubicin tissue uptake and clearance
Tumor tissues were treated with doxorubicin for a fixed period of time to measure its
uptake and clearance. Doxorubicin delivered through the channels was taken up rapidly
by tissue (Fig. 3.22A). The amount of drug in tissue increased continuously till 10.5
hours (Fig. 3.22B). The drug concentration in tissue was significantly higher (P<0.05,
n=3) than in the channels (Fig. 3.22B). After the drug was cleared from the channels, the
amount of drug in tissue did not decrease rapidly. At 20 hours, the average amount of
drug in tissues was 86% of the maximum amount (at 12 hours), showing that only 14% of
the drug cleared from tissue in 8 hours (Fig. 3.22B). From 12 to 20 hours, the
concentration of drug in the front region of tissue decreased (Fig. 3.22C). At the rear end,
concentration profiles flattened out and the concentration at 20 hours was higher than at
12 hours (Fig. 3.22C).

3.5.4 Doxil tissue uptake and clearance
Tumor tissues were treated with Doxil for a fixed period of time to measure its uptake
and clearance. The amount of Doxil taken up in tissue increased when it was delivered
through the channels (Fig. 3.23A). Unlike doxorubicin, the average concentration in
tissue was not significantly higher than in the channels (Fig. 3.23C). After 8 hours, Doxil
was cleared from the channels, which resulted in rapid clearance of drug from tissue (Fig.
3.23A,C). At 30 hours, the average amount of drug in tissue was 12% of the maximum,
showing that 88% of the drug was cleared from the tissue (Fig. 3.23A,C). For direct
comparison of the performance of Doxil with doxorubicin, the latter was delivered at 50
µM for 8 hours to tissues. Similar to the previous experiment (Fig. 3.22), the
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concentration of doxorubicin in tissue was significantly higher than in the channels, and
the clearance of doxorubicin from tissues was gradual (Fig. 3.23B,D). Doxorubicin
concentration in tissue was significantly higher (P<0.05, n=3) than Doxil throughout the
experiment (Fig. 3.23E).

3.5.5 Parameter optimization
Experimental data were used to evaluate the diffusivity of doxorubicin, D, its binding
constant, R, and the maximum concentration of binding sites, Smax (Table 3.2). Whole
tissue drug concentration over time (Fig. 3.24A) and spatiotemporal profiles (Fig. 3.24B)
obtained using optimized parameters matched experimental data well. These parameter
values were then used to solve the liposome encapsulation model. Experimental data
from Doxil treatment were used to evaluate the rate of drug release, krel, the ratio of
liposome to free drug diffusivity, M = Dlip/D, and the liposome partition coefficient, PC
(Table 3.2). Average tissue concentrations (Fig. 3.24C) and spatial profiles (Fig. 3.24D)
evaluated using optimized parameters matched experimental profiles well. The important
phenomena captured by these models were the gradual clearance of doxorubicin (Fig.
3.24A) and the rapid clearance of Doxil (Fig. 3.24C) from tissue.

3.5.6 Location of doxorubicin and Doxil on parameter-response maps
Optimal parameter values were used to locate the position of doxorubicin and Doxil on
diffusivity, binding and release maps. First, assuming that doxorubicin did not bind to
tissue, the model was solved to obtain the effect of diffusivity. The diffusivity of
doxorubicin, D = 2.86x10-11 m2/s, lay at point a (Fig. 3.25A). For D, the model was

85	
  

solved to observe the effect of binding. The binding constant for doxorubicin, R = 48.6
µM-1, lay at point b (Fig. 3.25B). For D and R, the half-life of doxorubicin, Thalf = 0.2
hours, lay at point c (Fig. 3.25C). For D, R, and evaluated Doxil parameters, M = 0.13,
PC = 1.34 (Table 3.2), a krel - Thalf map was drawn. Doxil, half-life 50 hours, lay at point d
on the map (Fig. 3.25D).

3.5.7 Discussion
The microfluidic devices used for these experiments mimic regions of tumors adjacent to
blood vessels. Drug delivery was mimicked by flowing drug through the channels of the
device and clearance was mimicked by flushing the channels with drug-free medium. The
construction of the device with transparent materials allowed visualization of the entire
cross section of tissue, facilitating quantification of drug spatiotemporal profiles. This is
the first in vitro device that has been exclusively designed to measure drug transport in
tumors.

The PK/PD-Transport-Reaction model was developed to capture important mechanisms
that govern drug distribution in tumors (Eqns 9-11; Fig. 3.20). The contribution of
individual mechanisms was clarified by using limiting cases. In absence of transport
limitations and clearance, the live cell fraction decreased at the maximum death rate,

µdmax (Fig. 3.20A). This situation predicts the effect of the drug on a monolayer of cells
and reduces the model to a classical PD model. A standard dose response curve, typical
of PD models, could be obtained from this model (inset; Fig. 3.20A). When a nominal
clearance rate (PK) was introduced, the drug induced lesser therapeutic effect (Fig.
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3.20B), as expected. PK/PD models can predict this limited response. Conventional
wisdom would suggest that when transport limitations are imposed on this drug, it would
further reduce its efficacy. However, there was an increase in therapeutic response when
a nominal diffusivity was introduced (Fig. 3.20C). This was a result of the additional
drug-tissue contact time attained by decreased rate of clearance from tissue. Binding of
this drug to specific sites within tissue further decreased the rate of clearance and
enhanced the therapeutic effect (Fig. 3.20D). Limited transport in tumor tissue may
enhance as well as reduce a drug’s efficacy (Fig. 3.20E). There is a limit to the benefits of
increasing drug-tissue contact time by decreasing diffusivity. When the diffusivity is very
low, drugs cannot enter tissue and the therapeutic effect decreases (Fig. 3.20E). Further,
there is a complex interaction between binding and diffusion (Fig 3.20F). For low
diffusivities, increasing binding has an unfavorable effect (dark lines; Fig. 3.20F) because
binding prevents deep penetration. There exists an optimal diffusivity where the
therapeutic effect is strong and nearly independent of binding (gray line, Fig. 3.20F). For
diffusivities higher than the optimum, increasing binding is favorable because it increases
drug-tissue contact time by preventing rapid clearance of the drug (dotted lines; Fig.
3.20F). In essence, binding is unfavorable for large molecules that are limited by
diffusion and favorable for small molecules that diffuse rapidly.

The competing effects of liposome encapsulation were elucidated by drawing krel - Thalf
and Dlip - Thalf maps (Fig. 3.21D-G). The far right regions on these maps (high release
rates or high diffusivities) represent non-encapsulated drugs. The benefits of increased
circulation time obtained by drug encapsulation may be offset by limited drug release or
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diffusion. For example, increasing the half-life of drug D1 from 1 hour (point a; Fig.
3.21D) to 5 hours improves its efficacy taking it to point b (Fig. 3.21D). However, this
effect is offset for log krel < -3.3, producing a less effective drug (point c; Fig. 3.21D).
Strong-binding drugs like D2 are not limited by rapid clearance and kill a significant
fraction of live cells at a half-life of 1 hour (point d; Fig. 3.21E). Increasing the half-life
of such drugs to 5 hours by encapsulation does not significantly shift the location of the
drug on the map. Further, if the release rate from the liposome is low (log krel ≤ -3.3), the
efficacy of this drug decreases (point e; Fig. 3.21E). Drug D2 is not a strong candidate for
liposome encapsulation.

The effects of reduced diffusivity as a result of encapsulation on weak-binding drugs like
D1 are strong (Fig. 3.21F). Decreasing log (Dlip/D) below -3 eliminates the therapeutic
effect of the drug (Fig. 3.21F). The favorable effects obtained by increasing the half-life
of D1 from 1 hour (point e; inset; Fig. 3.21F) to 5 hours (point f; inset; Fig. 3.21F) are
offset for log (Dlip/D) < -1.25. All resulting drugs below this diffusivity were less
effective (point g; Fig. 3.21F) than the original drug, point e. The effects on strong
binding drugs, like D2, are not significant for reductions over several orders of magnitude
(Fig. 3.21G). For log (Dlip/D) > 3, there is no effect of reduced diffusivity (inset; Fig.
3.21G). The effects of liposome encapsulation, therefore, depend strongly on the
characteristics of the free drug as well as the liposome. A careful analysis of these factors
must precede any major efforts taken towards developing encapsulated drugs.
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Tissues treated with doxorubicin and Doxil displayed certain important characteristics of
the two drugs. Minimal tissue clearance of doxorubicin shows that it binds tissue strongly
(Fig. 3.22,3.23). Retention in tissue was most likely a result of DNA intercalation
(Gewirtz 1999; Sartiano et al. 1979). Strong tissue-binding explains the long terminal
half-life of doxorubicin after rapid initial clearance from plasma, as observed in humans
(Benjamin et al. 1977). DNA intercalation also explains the higher concentration of
doxorubicin in tissue compared to channels (Fig. 3.22,3.23). The rapid clearance of Doxil
from tissue (Fig. 3.23) shows that there was minimal intra-tissue drug release.
Doxorubicin released from Doxil would be expected to bind to tissue, but there was no
drug retention detected in the experiments (Fig. 3.23). The temporary local increase in
tissue intensities compared to channel intensities (Fig. 3.23A) can be attributed to
selective partitioning of liposomes in tissue.

Experimental data from doxorubicin and Doxil treatment were used to evaluate all the
key parameters involved in the PK/PD-Transport-Reaction and the liposomeencapsulation model (Fig. 3.24). Evaluated parameters were used to map the location of
the two drugs on parameter-effect relationships (Fig. 3.25). Doxorubicin lies very near to
the minimum on the diffusivity-response curve (point a; Fig. 3.25A). The binding
constant of doxorubicin lies at point b on the binding constant-response curve (Fig.
3.25B), also very near to the minimum. The success of doxorubicin as one of the most
widely used chemotherapeutic agents may partly be attributed to this optimal location of
the drug on the diffusivity-binding-response maps. Doxorubicin is rapidly cleared from
plasma in humans with a half-life of 0.2 hours (Benjamin et al. 1977). It lies at point c on
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the half-life response curve (Fig. 3.25C) and its therapeutic effect can be enhanced by
increasing its half-life. Doxil was designed to increase the circulation time of doxorubicin
and has a half-life in humans of approximately 50 hours (Gabizon et al. 1994).
Doxorubicin lies at point e on the krel-Thalf map (for M = 0.13; Fig. 3.25D). Increasing
half-life from 0.2 to 50 hours takes it to point f (Fig. 3.25D), but the slow release rate
shifts Doxil to point d (Fig. 3.25D) and no therapeutic effect. Under the experimental
conditions utilized, Doxil was severely limited by slow drug release (Fig. 3.23). Limited
release may explain why Doxil has been successful for only a few cancers. The benefits
of Doxil must primarily emerge from low toxicity due to minimal systemic drug release
(Immordino et al. 2006). Limited drug release at the tumor site seems to be a significant
limitation to the therapeutic effect of Doxil. Engineered liposomes that can selectively
enhance drug release within tumors may radically enhance therapeutic response.
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Table 3.1 Oxygen-dependent growth and death parameters
Parameter

Value

Maximum death rate
Oxygen growth saturation
constant
Oxygen death saturation
constant

µd,max

0.0275 hr-1

Kg,ox

4.64 x 10-3 mM

Kd,ox

4.17 x 10-2 mM

Table 3.2 Evaluated parameter values for doxorubicin and Doxil
Parameter

Description

Value

Doxorubicin
D

Diffusivity

(2.86 ± 1.15) x 10-11
m2/s

R

Binding constant

48.6 ± 24.4 µM-1

Smax

Maximum binding site concentration

42.8 ± 5.6 µM

Doxil
krel

Rate of release from liposome

(6.05 ± 0.18) x 10-11 s-1

M

Ratio of liposome to free drug
diffusivity

0.13 ± 0.02

PC

Partition coefficient

1.34 ± 0.09
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Figure 3.1 Positioning of cylindroids and oxygen formation. A. Transmitted light image
of the chip showing the location of the electrolyte reservoir, cathode, and the anode.
Scale bar is 1 mm. Inset: Enlargement of the tip of the anode where oxygen is generated
and square PDMS support posts. Scale bar is 50 µm. B. Transmitted light image of a
cylindroid positioned over the anode. Scale bar is 100 µm. C: Transmitted light images
of oxygen bubble generated at the anode. Scale bar is 100 µm. D: Size of the generated
bubble as a function of time. The size of the bubble increased when the electrolysis
current was on and decreased after it was turned off. Inset: When the electrolysis current
was applied the oxygen generation rate was constant.
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Figure 3.2 Estimation of maximum cell growth rate. A. Transmitted light images of cells
10, 17.5, 25 and 32.5 hours after plating. Dotted lines represent total area occupied by
cells. B. Total area occupied by cells increased exponentially.
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Figure 3.3 Effects of oxygen on cell death in tissue. A-F. Transmitted light, Eth-D1
fluorescence, and radial viability (% dead) profiles of control (A,B,C) and oxygenated
(D,E,F) cylindroids. Images were acquired after 60 hours of incubation with continuous
oxygen delivery (treatments) and no oxygen delivery (controls). G. Oxygenation
decreased overall tissue death after 60 hours of incubation (*, P<0.05). H. Comparison of
cell death between oxygenated and control cylindroids in the inner 50% and outer 20% of
cylindroids. Oxygenation prevented cell death in the inner regions of cylindroids and
resulted in accumulation of dead cells at the peripheries (*, P<0.05).
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Figure 3.4 Oxygen mediated cell rearrangement. A,B. Location of a dead cell within an
Eth-D1 stained cylindroid 6.5 and 10.5 hours after the start of oxygenation. C. Percent
change in location of six cells relative to their starting positions. D. Suggested
mechanism of cell rearrangement involving active motion of live cells (solid arrows) in
response to oxygen gradients, causing passive motion of dead cells (dashed arrows).
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Figure 3.5 Mathematical model results. A. Steady state oxygen concentration profile
through a vertical slice along the cylindroid diameter. Bright spot at the center is a region
of high oxygen concentration near the source, and the concentration decreases away from
the center. B. Steady state radial oxygen concentration profiles at the base of control (0
µA) and oxygenated (0.1 µA) cylindroids. C. Calculated growth rate, µg, and death rate,
µd, of cells in cylindroids as a function of oxygen concentration, as determined by fitting
to the viability profiles. D,E. Simulated oxygen concentration profiles in cylindroids for
controls (D) and treatments (E), using the dynamic model of cell growth and death.
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Figure 3.6 Cellular uptake/release of FITC-AuNPs. A and B. Transmitted and red
fluorescent images of viable (A) and dead (B) cells in monolayer culture treated with
positive Dox-AuNP. C. Normalized fluorescence intensities of viable and dead cells
following uptake of viability stain Eth-D1, positive Dox-AuNP and negative Dox-AuNP.
Error bars are standard error of the mean (n=9). Scale bars are 50µm.
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Figure 3.7 Doxorubicin release in cylindroids. A,B and C, Red fluorescence images and
the corresponding radial intensity profiles of cylindroids treated with positive Dox-AuNP
(A), negative Dox-AuNP (B) and free Dox (C). Dotted circles indicate cylindroid edges.
Scale bars are 200µm. D and E, Ratio of average fluorescence intensities in the outer
region to those in the inner region of cylindroids, 30 hours after treatment (D) and as a
function of time (E). Errors are standard error of the mean (n=3).
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Figure 3.8 Tissues in culture chambers. A. Tissue introduced into a culture chamber on
the microfluidic device. B. Apoptosis in tissue over 3 days measured using an active
caspase-3 fluorescent dye.
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Figure 3.9 The effect of height difference between tissues and outlet valves on stability.
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Figure 3.10 Increasing device throughput. A. Tissues introduce into four chambers on a
six-chamber serial device. Scale bar is 300 µm. B. 48 culture chambers arranged so that 8
treatments can be tested against 6 tissues each, optimized to fit on a glass slide.
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Figure 3.11 Automatic tissue introduction. Tissues introduced into all 6 chambers of a
serial device using an automated syringe pump.

Figure 3.12 Spheroids made by the hanging-drop method.

102	
  

Figure 3.13 Time-dependent concentration profiles. Single exponential (A) and double
exponential decays (B) mimicked using automated syringe pumps.
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Figure 3.14 Variation in motility of four bacterial strains. A. Bacterial motility was
measured by time-lapse fluorescence imaging. Salmonella strains SL1344 and
VNP20009 were visibly motile (white arrows) and E.coli strains K12 and DH5α (white
arrows) were less motile. Scale bar is 25 µm. B. Average swimming velocity of SL1344
and VNP20009, in DMEM, was greater (*, P<10-4) than K12 and DH5α. C. SL1344 and
VNP20009 had bimodal and K12 and DH5α had unimodal velocity distributions. D.
Fractions of SL1344 and VNP20009 were highly motile and these fractions were greater
(*, P<0.05) than K12 and DH5α, which did not contain highly motile fractions. E. K12
and DH5α had unimodal population velocity distributions. F. The entire populations of
E.coli strains were either non-motile or minimally motile. DH5α had a greater (*,
P<0.01) fraction of non-motile bacteria than K12.
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Figure 3.15 Accumulation of different bacterial strains in tumor tissue. A. Merged green
fluorescence and transmitted light images of tissues at 30 hours. Scale bar is 500 µm.
Images of tissues were obtained over time, following 1-hour bacterial treatment and
flushing. There was considerable difference in accumulation between strains. B.
Accumulation in flow channels after 10 hours was significantly less (*, P<0.05; n=3) than
tissue. C,D. Accumulation in tissue increased over time for 105 CFU/ml inoculation (C;
n=3) and for 107 CFU/ml inoculation of E.coli strains (D; n=3). E. For 105 CFU/ml
inoculation, accumulation at 30 hours correlated strongly (R2=99.27%) with velocity.
Accumulation of SL1344 was greater (*, P<0.05, n=3) than all other strains and
VNP20009 was greater (*, P<0.05, n=3) than E.coli strains. F. For 107 CFU/ml
inoculation, K12 had higher (*, P<10-3) velocity (white bars) and greater (*, P<10-3, n=3)
accumulation (black bars) at 30 hours.
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Figure 3.16 Spatial distribution of bacterial accumulation in tissue. A,B. Merged green
fluorescence and transmitted light images of tissues treated with four bacterial strains at
105 CFU/ml at 15, 25 and 30 hours (A), and tissues treated with E.coli strains at 107
CFU/ml at 15, 25 and 34 hours (B). Scale bar is 500 µm. Color scales are provided to
distinguish magnitudes of accumulation. At 105 CFU/ml, maximum density of SL1344
and VNP20009 was approximately 1010 and 109 CFU/g, respectively. At 107 CFU/ml,
maximum density of K12 and DH5α was approximately 1010 and 108 CFU/g,
respectively. C,D. 30-hour bacterial density profiles for SL1344 and VNP20009 at 105
CFU/ml (C; n=3) and K12 and DH5α at 107 CFU/ml (D, n=3). Magnitudes of densities
differed considerably (y-axis scales). E,F. 30-hour zone-1 (black bars) and zone-2 (white
bars) accumulation at 105 CFU/ml (E; n=3) and of E.coli strains at 107 CFU/ml (F; n=3).
Zone-1 accumulation was significantly greater (*, P<0.05) for all strains except SL1344.
G. At 30 hours, penetration depth of SL1344 was greater (*, P<0.05; n=3) than all other
strains and of DH5α was less (*, P<0.05; n=3) than all other strains.
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Figure 3.17 Mathematical modeling of bacterial penetration and growth. A. 30-hour
simulated and experimentally observed bacterial density profiles in tissue. Experimental
data was fit to Eq. 1 to obtain optimized values of dispersion coefficient, D, and growth
rate, µ, for each strain. Simulated profiles were generated for optimized parameter values.
B. Dispersion coefficients of the four strains. SL1344 had the greatest (*, P<0.05; n=3)
dispersion coefficient. C. Growth rates of the four strains. Growth rates decreased (*,
P<0.05; n=3) progressively in the order SL1344, VNP20009, K12 and DH5α D,E,F.
Correlation between dispersion coefficient, D, and 30-hour penetration depth (D); growth
rate, µ, and 30-hour normalized bacterial accumulation (E); and average velocity and
dispersion coefficient, D (F). G,H. 30-hour bacterial density profiles generated for
nominal values of dispersion coefficient, D = 0.02, 0.07 and 0.17 µm2/s, and growth rate,
µ = 0.57 hr-1 (G), and D = 0.1 µm2/s, µ = 0.55, 0.57 and 0.60 hr-1, at 30 hours (H).
Increasing D caused bacteria to penetrate deeper and increasing µ increased the density of
accumulation.

107	
  

Figure 3.18 Apoptosis induction in tissue. A. Merged green fluorescence and transmitted
light images (top row), and merged red fluorescence and transmitted light images (bottom
row) of SL1344-treated tissue. Green fluorescence corresponds to ZsGreen-expressing
bacteria and red fluorescence corresponds to an active-caspase-3 marker, Red-DEVEFMK. Scale bar is 500 µm. B. Normalized fluorescence intensities from red and green
fluorescent images of SL1344-treated and control tissues (n=3). Inset: Data plotted as
normalized increase in apoptosis intensity against bacterial intensity for treated tissue
(n=3). Accumulation correlated strongly (R2 = 98.6%) with apoptosis over 30 hours. C.
Spatial distribution of bacterial accumulation and apoptosis induction in SL1344-treated
tissues and controls, at 30 hours (n=3). Inset: Data plotted as normalized increase in
apoptosis intensity against bacterial intensity (n=3). At 30 hours, accumulation correlated
strongly (R2 = 92.90%) with apoptosis. D. Apoptosis in zone-1 of SL1344-treated tissue
at 30 hours was greater (*, P<0.05; n=3) than zone-2. E. Normalized increase in whole
tissue apoptosis for control tissues and different bacterial treatments at 105 CFU/ml
(n=3). Only Salmonella strains increased (*, P<0.05) apoptosis in tissue.
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Figure 3.19 Bacterial penetration and spreading in tumors. A. Simulated 30-hour
bacterial density distribution profiles for VNP20009, and a hypothetical strain that
contains only the highly motile fraction of VNP20009. Elimination of less motile bacteria
increased penetration. B. The hypothetical strain containing highly motile bacteria causes
apoptosis farther than 800 µm from blood vessels. C,D. Proposed mechanism for
penetration and accumulation of motile bacteria (C) and non-motile bacteria (D) in
tumors. Motile bacteria are able to disperse, find favorable microenvironments, and
colonize near and far from blood vessels. Non-motile bacteria colonize near blood vessels
and slowly penetrate by growth and division.
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Figure 3.20 Effects of diffusivity and binding. The PK/PD-Transport-Reaction model
was solved for limiting cases to explain the effect of each component of the model. A.
Pharmacodynamic response was predicted by eliminating transport, binding, and
clearance. The drug killed cells at the maximum rate µdmax. B. PK/PD response was
predicted by adding a nominal clearance rate, Thalf = 0.5 hours. Clearance reduced drug
efficacy. C. Effects of transport were predicted by introducing a nominal diffusivity, D =
2x10-11 m2/s. This improved the therapeutic response. D. Effects of binding were
predicted by introducing a nominal drug binding constant, R = 0.1 µM-1. Binding further
improved therapeutic response. E. Limited diffusion can increase as well as decrease
therapeutic response. An optimal diffusivity exists that maximizes therapeutic effect. F.
The interaction between diffusivity, D, and binding, R, is complex. Binding can enhance
as well as reduce drug efficacy, depending on diffusivity.
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Figure 3.21 Effects of liposome encapsulation. The effects of liposomal encapsulation
depended on the characteristics of the encapsulated drug. The effects were predicted for
two hypothetical drugs, weak-binding drug D1 and strong-binding drug D2. A. Increasing
half-life, Thalf, improved therapeutic response of D1 considerably. D2 was not limited by
rapid clearance and increasing the half-life did not improve its efficacy. B. Decreasing
the rate of drug release, krel, strongly decreased the therapeutic effect of D1 and D2. C.
The diffusivity of liposomes, Dlip, is lower than the diffusivity of the encapsulated drug,
D, and their ratio considerably affected therapeutic response. For D1, decreasing Dlip
strongly decreased therapeutic effect. For D2, the effect was minimal. Inset: Effect of
Dlip/D over three orders of magnitude. D-E. krel-Thalf maps for D1 (D) and D2 (E). F-G.
Dlip-Thalf maps for D1 (F) and D2 (G). These maps put improvement in therapeutic
response by increasing Thalf and decrease in response by decreasing Thalf and krel into
perspective.
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Figure 3.22 Doxorubicin treatment. A: Fluorescent images of colon carcinoma tissue in
microfluidic devices treated with 5 µM doxorubicin for 10.5 hours, showing the uptake
and clearance of the drug. Scale bar is 300 µm. B. Average normalized fluorescence
intensities from channels and tissue over 20 hours. The fluorescence intensities in tissue
were significantly higher (*, P<0.05, n=3) than in channels. The clearance of doxorubicin
from tissue was gradual. C. Spatial profiles of doxorubicin drug concentration. Drug
concentration in the front part of tissue was higher during penetration. During clearance,
the concentration profiles flattened.
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Figure 3.23 Doxil and doxorubicin treatment. A-B: Fluorescent images of colon
carcinoma tissue in microfluidic devices treated with 50 µM Doxil (A) and 50 µM
doxorubicin (B) for 8 hours, showing the uptake and clearance of the two drugs. Scale
bar is 300 µm. C-D. Average normalized fluorescence intensities from channels and
tissue for Doxil (C) and doxorubicin (D) over 20 hours. Doxil cleared from tissue rapidly
and doxorubicin cleared gradually. E. Comparison of normalized tissue fluorescence
intensities of doxorubicin and Doxil. Doxorubicin treated tissues had significantly greater
(*, P<0.05, n=3) fluorescence than Doxil treated tissues.
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Figure 3.24 Results from experimental data fitting. A-B. Experimental and simulated
average tissue intensities (A) and spatial profiles (B) over time for doxorubicin. C-D.
Experimental and simulated average tissue intensities (C) and spatial profiles (D) over
time for Doxil. Simulated profiles matched experimental profiles well.
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Figure 3.25 Mapping the location of doxorubicin and Doxil. A. Diffusivity-response map
shows that the diffusivity of doxorubicin, 2.86 x 10-11 m2/s, lies very near to the optimal
diffusivity for maximizing therapeutic effect (point a). B. Binding-response map shows
that doxorubicin has a high binding constant, 48.6 µM-1, which lies very near to the
optimal binding constant for maximizing therapeutic effect (point b). C. Half-life
response map shows that a short half-life, 0.2 hours, limits the therapeutic effect of
doxorubicin (point c). D. krel-Thalf-response map for Doxil. At half-life of 0.2 hours,
doxorubicin lies at point e. Doxil increased the half-life to 50 hours (point f), but had a
very low tissue drug release rate. Doxil lies at point d and has a severely limited
therapeutic response.
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CHAPTER 4
CONCLUSIONS

This dissertation has focused on measuring the transport of cancer therapeutics and its
effects on tumor tissues. Limited transport has been known to affect tumor progression
and limit the efficacy of cancer therapies. Tumors are chaotic systems and it has been a
challenge to accurately measure the effects of limited transport. In vitro systems can
simplify the measurement and analysis of these effects but suitable in-vitro systems that
capture transport phenomena have been scarce. In this dissertation, I have described the
development of technologies that mimicked tumor regions near vasculature and pose
transport limitations to the penetration of drugs and nutrients. This work has an impact
not only because the results obtained from the specific systems utilized for experiments
are valuable, but also because the technologies and methods that were developed along
the way have broader applications related to cancer drug development.

Tumor oxygen microenvironments have been a field of extensive study. In this
dissertation,

I

present

experiments

that

have

approached

tumor

oxygen

microenvironments and their effects from a new angle. A device to deliver micrometerscale oxygen to three-dimensional tumor tissue in vitro was developed. To the best of my
knowledge, this is the first report of high spatial resolution control over oxygen gradients
within scaffold-free three-dimensional tissue. Using a specially designed positioner,
cylindroids were placed over electrodes with a high degree of accuracy. This placement
enabled precise supply of oxygen to the necrotic center of cylindroids. Results obtained
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using the device showed that oxygenation reduced cell death in tumor tissue. A
mathematical model of cell viability showed that the rate of cell death was more sensitive
to oxygen concentration than the rate of cell growth. The results showed that oxygen is a
primary factor controlling cell viability in tumor, because other nutrient gradients were
not disrupted in oxygenated cylindroid. In the device oxygen caused considerable cellular
rearrangement and dead cells were observed moving toward the cylindroid edge. This
observation indicates that oxygen gradients are capable of restructuring tissues, a
mechanism that could lead to metastasis formation. Relocation of dying cells by oxygen
gradients may explain the previously observed correlation between hypoxia and
metastatic disease. These results demonstrate the importance of oxygen gradients in
controlling cell viability and rearrangement, and their role in cancer progression.

The delivery of gold-nanoparticle mediated doxorubicin to tumor tissue was mimicked
using the cylindroid model. Previous work in our lab had shown that the surface charge
of gold nanoparticles affected the rate and location of payload delivery using a
fluorescent molecule tagged to nanoparticles. To test the validity of these results for
chemotherapeutic agents, I used positive and negatively charged gold nanoparticles
covalently attached to doxorubicin. Positive gold nanoparticles were shown to release
doxorubicin preferentially in the proliferating regions of the cylindroids. Negative
particles released less drug and uniformly within the cylindroids. Positive particles seem
to be the ideal choice for the rapid delivering of drugs to proliferating tumors. Negative
particles may have an application in the slow release of drugs throughout entire tumors.
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A microfluidic device was developed and optimized for continuous culture of tumor
tissues. This device is a significant advancement in the current methods of tumor tissue
culture. The device mimicked heterogeneous tumor microenvironments as well as the
delivery and clearance of cancer therapeutics. Further, time-lapse microscopy allowed
visualization of the spatiotemporal dynamics of drug distribution as well as its effect on
tumors. Stable and long-term operation of this device presented challenges, which were
overcome by employing multiple techniques at each stage of development and arriving
upon the optimum set of conditions and design and operation parameters. At this point,
the device can simultaneously test the effects of two treatments on six tissues each.
Designs to expand the device to test 8 drugs have been made (Fig. 3.10B) but their
performance remains to be tested. These devices were used for making important
advances in the field of bacterial cancer therapy and chemotherapeutic drug development,
as described below.

The microfluidic device found its first application in measuring the effect of motility on
the spatiotemporal dynamics of bacterial accumulation in tumor tissue. The device was
used to mimic the delivery and clearance of two Salmonella strains and two E.coli strains.
Salmonella strains were significantly more motile than E.coli strains. The extent of
bacterial colonization in tumors increased with increasing motility. Motility also affected
the spatial distribution of bacterial accumulation within tissues and motile strains
penetrated deeper. These results suggest that for efficient solid tumor therapies, highly
motile strains should be selected. A mathematical model that described the relative
contribution of bacterial dispersion and growth to the location and extent of bacterial

118	
  

accumulation in tumors showed that dispersion leads to deeper penetration into tumors
and growth leads to increased bacterial densities. A combination of preferential growth
within tumor microenvironments and motility is therefore essential for maximizing
therapeutic efficacy. Bacterial accumulation caused apoptosis in tumors and the amount
of induced apoptosis correlated strongly with bacterial density. These results demonstrate
the importance of bacterial motility for tumor penetration, distribution and colonization,
and suggest that motile Salmonella have higher therapeutic potential than less-motile
E.coli. These results could not have been obtained by other in vitro tumor tissue models
that did not incorporate clearance because bacteria would have flooded the cell culture
medium by rapid growth, as has been observed by previous researchers in the Forbes lab.
It was necessary to mimic bacterial clearance and that was achieved by using the
microfluidic devices developed in this work.

In the last part of this work, I developed a pharmacokinetic/pharmacodynamic model that
incorporated

the

mechanisms

of

tissue-level

drug

transport

and

binding

(PK/PD/transport-reaction model). This work was initiated when I noticed that after
diffusing into tumor tissues on devices, doxorubicin bound to the tissues and did not
diffuse out after clearance from channels. The binding of drugs to tissue is not measured
by current in vitro drug development assays. The PK/PD-transport-reaction models
showed that the therapeutic efficacy of drugs is dependent on a complex interaction
between diffusivity and binding. This shows that it is important to measure these two
parameters independently early in the drug development process. The model further
shows that benefits of prolonged circulation achieved by liposome encapsulation may be
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offset by limited drug release and diffusivity into tissue. Doxorubicin and Doxil
experimental data obtained using devices fit the models well showing that the models
incorporated the necessary mechanisms required to predict drug distribution.

In this dissertation, I have shown that microfabricated devices can be designed to culture
tumor tissues to create different geometries and drug and nutrient gradients. Important
phenomena like oxygen deprivation, bacterial penetration, drug binding, and systemic
clearance can also be incorporated in these devices. Such integrated devices provide new
ways of understanding tumor development and provide excellent platforms for the
development of new cancer therapies.
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